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ABSTRACT 
The human ovary has a major role in the body’s endocrine and reproductive system. 
Understanding its cell type composition is crucial in order to study underlying mechanisms of 
hormonal balance and ovarian follicle maturation in health and disease. The outer lining of the 
ovary, the cortex, harbors the ovarian reserve. This reserve is made up of follicles that have 
formed before birth. The prevailing dogma of female fertility sees this reserve as being limited 
in humans, with follicle numbers decreasing over time. Once the ovarian reserve is depleted, 
women enter menopause which marks the end of their reproductive period. Premature ovarian 
insufficiency is characterized by an early depletion of the ovarian reserve and reveals itself, 
among others, with an altered hormone profile and early menopause onset. Anti-cancer 
treatment is one of the causes of premature ovarian insufficiency. However, mechanisms 
underlying chemotherapy-induced altered ovarian tissue morphology and function are not yet 
fully understood. Therefore, effective treatments to prevent or cure the damage are still missing. 
One possibility for novel treatments could be offered by oogonial stem cells (OSCs) that have 
been recently reported to exist in the adult human ovaries. These cells can be isolated with 
DDX4 antibody (Ab), show a gene expression profile similar to germline stem cells in the 
developing embryo and have the potential to mature into oocytes.  
 
The overall aim of this thesis is to assess the effect of first-line chemotherapy on ovarian 
follicles and stroma by using a tissue collection from fertility preservation programs and to 
dissect the structure of human ovarian cortex at single-cell resolution by using advanced single-
cell profiling technology. 
 
In study I, the effects of first-line chemotherapy that is not considered a risk for future fertility 
on ovarian follicles and stroma cells from pediatric and young adult ovaries were investigated. 
Exposure to chemotherapy prior to ovarian tissue cryopreservation revealed an impact on 
follicle and stroma health. Early ovarian follicles (primordial and intermediary) appeared more 
atretic and were smaller, while healthy growing follicles (primary) decreased in numbers. 
Steroid production by treated ovarian tissue in culture decreased and DNA damage as well as 
fibrotic lesions in the ovarian stroma increased. 
In study II, we assessed the cellular composition of the adult human ovarian cortex at a single-
cell level. Transcriptome and surface proteome analysis revealed six major cell types 
consistently detected in the ovarian cortex from Cesarean section and gender reassignment 
patients, namely oocytes, immune cells, granulosa cells, endothelial cells, perivascular cells 
and stroma cells. In order to investigate the existence of the previously reported OSCs, ovarian 
cortex cells positive for DDX4 Ab were isolated and analyzed. DDX4 Ab-positive cells did not 
show a germline-like profile, neither at a transcriptional nor protein level, but instead could be 
identified as perivascular cells. Furthermore, when integrating published single-cell sequencing 
data from fetal germ cells, we could not identify any cortex cell with a transcriptome profile of 
germline stem cells. 
 
In conclusion, we demonstrate that first-line chemotherapy treatment has negative effects on 
the health of ovarian cortex and exposure should be limited before cryopreservation of ovarian 
tissue, if possible. Adult ovarian cortex is made up of various cell types, but no evidence for 
the existence of germline-like stem cells was found.   
  
WISSENSCHAFTLICHE ZUSAMMENFASSUNG AUF 
DEUTSCH 
Der menschliche Eierstock spielt eine wichtige Rolle im Hormonhaushalt und in der 
Fortpflanzung. Um die zuständigen Mechanismen der Hormonproduktion und der Reifung der 
Eizellen in Bezug auf Gesundheit und Krankheit untersuchen zu können, ist es entscheidend, 
die zugrunde liegende Zell-Zusammensetzung des Eierstocks zu verstehen. Der äußere Teil des 
Eierstocks, der Kortex, beherbergt die sogenannte “Eierstockreserve“, die aus Follikeln besteht 
(ein Follikel enthält eine Eizelle, die umgeben ist von Helferzellen, auch Granulosazellen 
genannt), die bereits vor der Geburt im Embryo angelegt wurden. Das vorherrschende Dogma 
der weiblichen Fruchtbarkeit sieht diese Reserve als begrenzt an, wobei die Follikelzahl mit 
der Zeit drastisch abnimmt. Sobald die Eierstockreserve erschöpft ist, treten Frauen in die 
Wechseljahre ein, was das Ende ihrer Fortpflanzungsperiode bedeutet. Die Krebsbehandlung 
ist eine der Ursachen für eine vorzeitige sogenannte Ovarialinsuffizienz, für die eine drastische 
Verringerung der Eierstockreserve charakteristisch ist und die sich unter anderem mit einer 
veränderten Hormonproduktion und dem sehr frühen Beginn der Wechseljahre bemerkbar 
macht. Die Mechanismen, die der durch Chemotherapie induzierten Veränderungen im 
Eierstock zugrunde liegen, sind jedoch noch nicht vollständig verstanden. Neuere Studien 
berichten über die Existenz von sogenannten oogonialen Stammzellen (OSCs), die mithilfe von 
DDX4-Antikörpern isoliert werden können. Diesen Studien zufolge ähneln OSCs den 
Keimbahnstammzellen im sich entwickelnden Embryo und haben das Potenzial, zu Eizellen 
zu reifen. OSCs wurden als mögliche Behandlungsmethode in der künstlichen Befruchtung in 
Betracht gezogen, und bereits an bestimmten Kliniken angeboten. 
 
Das übergeordnete Ziel dieser Arbeit war es, die Wirkung der Chemotherapie auf Eizelle und 
Stroma herauszuarbeiten, sowie den menschlichen Eierstock in seiner Zell-Zusammensetzung 
zu verstehen. 
 
In Studie I wurden die Auswirkungen einer Chemotherapie auf Follikel und Stromazellen von 
Eierstöcken bei Kindern und jungen Erwachsenen untersucht. Die Behandlung mit 
Chemotherapie vor der Kryokonservierung des Eierstockgewebes zeigte einen negativen 
Einfluss auf die Gesundheit der Follikel und des Stromas. Unreife Follikel schienen atretischer 
und kleiner zu sein, während die Anzahl der gesunden, wachsenden Follikel abnahm. Die 
Hormonproduktion von Eierstockgewebe in Kultur nahm ab und DNA-Schäden sowie 
fibrotische Läsionen im Stroma nahmen zu. 
In Studie II haben wir die zelluläre Zusammensetzung des adulten menschlichen Eierstock-
Kortex` auf Einzelzellebene untersucht. Die Transkriptom- und Oberflächenproteomanalyse 
ergab sechs Hauptzelltypen, die im Eierstock-Kortex von Patienten mit Kaiserschnitt und 
Geschlechtsumwandlung konsistent nachgewiesen werden konnten. Die sechs identifizierten 
Zelltypen sind Eizellen, Immunzellen, Granulosazellen, Endothelzellen, perivaskuläre Zellen 
und Stromazellen. Um die Existenz der zuvor berichteten OSCs zu untersuchen, wurden DDX4 
Antikörper-positive Zellen isoliert und analysiert. DDX4 Antikörper-positive Zellen zeigten 
weder auf Transkriptions- noch auf Proteinebene ein Profil, welches Keimbahnzellen ähneln 
würde. Allerdings konnten sie als perivaskuläre Zellen identifiziert werden. Perivaskuläre 
Zellen sind verantwortlich für die Stabilisation und Kontraktion von Blutgefäßen. Darüber 
hinaus – und unabhängig von DDX4 Antikörper-positiven Zellen – konnten wir keine einzelne 
Zelle im adulten Kortex identifizieren, die den Keimbahnstammzellen eines Embryos ähneln 
würden. 
 
Zusammenfassend zeigen wir, dass eine Chemotherapie negative Auswirkungen auf die 
Gesundheit des Eierstockgewebes hat und soweit möglich begrenzt werden sollte bevor die 
Patientin Teile des Eierstocks kryokonserviert. Der adulte Eierstock besteht aus sämtlichen 
verschiedenen Zelltypen, allerdings wurden keine Hinweise auf die Existenz 
keimbahnähnlicher Stammzellen gefunden. Somit konnte hier das vorherrschende Dogma 
einer begrenzten Eierstockreserve bestätigt werden.  
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  1 
1 INTRODUCTION 
1.1 THE HUMAN OVARY 
Structure and function  
Ovaries are central reproductive organs in women with two major functions: production of 
hormones (steroidogenesis) and generation of developmentally competent mature oocytes 
(folliculogenesis). There are two ovaries, located on either side of the abdomen, connected to 
the uterus via the fallopian tubes (Fig.1A). The adult ovary consists of an outer part, the cortex, 
and an inner part, the medulla (Fig.1A, B). They are lined with an epithelial cell layer (also 
called human ovarian surface epithelium). The ovaries are highly plastic structures that allow 
for rupture and subsequent healing of the ovary surface when oocytes are being ovulated every 
month (Auersperg et al., 2001).  
 
Human ovarian follicles are formed during fetal life and can remain in a dormant state of so-
called primordial follicles for decades. Primordial follicles can be found in the cortical tissue 
and are composed of an oocyte and surrounding granulosa cells (Fig.1C). During the process 
of folliculogenesis (as described in more detail later), the primordial follicle becomes activated 
and starts to grow: the oocyte grows in size, granulosa cells proliferate, and theca cells 
differentiate to surround the growing follicle. During this process, the follicle migrates inwards 
to the medullary region of the ovary. The mature follicle finally releases the oocyte which can 
be fertilized by one spermatozoon to become an embryo. 
 
During follicle growth and maturation, the oocytes are in bi-directional communication with 
somatic cells within the ovary, which is necessary for oocyte development and normal 
functioning of the ovary (Kristensen et al., 2014). Granulosa cells are in physical contact with 
the oocyte. Communication happens mainly via paracrine factors through transzonal 
projections (TZPs) of granulosa cells reaching the oocyte surface (El-Hayek et al., 2018). First 
discovered over 50 years ago (Hadek, 1965), it has now been shown that TZPs connect 
granulosa cells and the oocyte through adherens junctions. Adherens junctions are found in 
tubulin-rich TZPs. While actin-rich TZPs make up the majority of TZPs and contain gap 
junctions that are responsible for signaling to and nutritional support of the oocyte (Li et al., 
2013). In addition, bi-directional communication is ensured via signaling molecules of the 
transforming growth factor-ß (TGF-ß) superfamily. The TGF-ß superfamily includes bone 
morphogenetic proteins (BMPs), growth differentiation factors (GDFs), inhibins, activins, 
follistatin and anti-Müllerian hormone (AMH) (Chang et al., 2016). Furthermore, the growth 
factor Kit ligand (KITL) is expressed by granulosa cells and signals to the oocyte via its 
receptor C-Kit, playing a key role in follicle development (Carlsson et al., 2006). 
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Fig.1 Physiology and anatomy of the human ovary. (A) The ovaries are connected to the uterus via 
fallopian tubes and are composed of an outer cortex and an inner medulla. A single layer of epithelial 
cells covers the cortical surface (marked with *). In cortex and medulla, many different cell types and 
structures can be found. Within the ovaries, the maturation of follicles occurs in a process termed 
folliculogenesis. It takes several menstrual cycles for the follicle to fully mature and reach the pre-
ovulatory stage. Graphics depicting folliculogenesis adapted from (Gougeon, 1996) with permission 
and (A) was created using ©BioRender. (B) The ovarian cortex is approximately 1 mm thick and 
harbors the ovarian reserve. This reserve contains the primordial follicles arrested in a dormant state. 
Only upon activation, primordial follicles start to grow and mature, moving towards the more 
vascularized medullary region of the ovary. (C-G) The early stages of follicle maturation are shown. 
Ovarian tissue sections were stained with hematoxylin and eosin. (C) Primordial follicle; dotted circle 
surrounds the oocyte nucleus for better visualization, black arrow points at one flattened granulosa 
cell surrounding the oocyte. (D) Intermediary follicle with both, flattened and cuboidal granulosa 
cells. (E) Primary follicle with one entire layer of cuboidal cells. (F) and (G) show secondary follicles 
as granulosa cells proliferate and form several layers. Scale bar = 50 μm. 
 
Besides signaling via growth factors, ovarian follicles are regulated by and produce steroid 
hormones. These hormones provide a feedback mechanism for regulation of reproduction 
known as the hypothalamic-pituitary-gonadal (HPG) axis (Rabinovici, 1993) (Fig.2). The HPG 
axis becomes activated during puberty: the hypothalamus produces gonadotropin-releasing 
hormones (GnRH) that act on the anterior pituitary. Here, GnRH stimulate endocrine cells to 
release the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH). 
Both hormones are needed to activate steroidogenesis in ovarian somatic cells, with granulosa 
cells and theca cells being significantly involved in steroid hormone production. LH binds to 
theca cells in the ovary via LH receptor (LHR). Theca cells further convert cholesterol into 
androgens, such as androstenedione and testosterone, by the enzymes desmolase (or CYP11) 
and CYP17. When FSH binds to granulosa cells via FSHR, aromatase (or CYP19) is activated 
and can now convert androgens into estrogens, including estradiol and estrone (Andersen et 
al., 2014). Upon ovulation of the oocyte, a corpus luteum is formed from the follicle remnants 
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(theca and granulosa cells) that secretes progesterone which is essential in preparing the uterus´ 
receptivity for potential embryo implantation. Via negative feedback, estrogen and 
progesterone inhibit the further production of GnRH in the hypothalamus and gonadotropins 
in the pituitary. When the oocyte remains unfertilized, the corpus luteum degenerates and 
ceasing levels of progesterone and inhibins secreted by the degenerating corpus luteum allow 
for a new cohort of follicles to grow and mature by the secretion of FSH from the pituitary 
(Gilbert, 2000).  
 
Folliculogenesis requires several months (Williams et al., 2000) and out of million primordial 
follicles formed before birth, approximately 400 oocytes are being ovulated before a woman 
enters menopause (Wallace et al., 2010). 
 
 
 
 
 
 
 
 
 
Fig.2. Hypothalamic-
pituitary-gonadal axis and 
regulation of ovarian 
folliculogenesis. The HPG 
axis controls the menstrual 
cycle by regulating the release 
of ovarian hormones. GnRH 
produced in the hypothalamus 
stimulates the release of LH 
and FSH in the anterior 
pituitary. LH and FSH, in turn, 
trigger the production of 
androgen, estrogen and 
progesterone in the ovary. 
Progesterone and estrogen 
exert an inhibitory effect on 
hypothalamus and pituitary to 
downregulate further GnRH 
release. Graphics was created 
using ©BioRender. 
 
Cell types in the human ovary  
In addition to the four cell types mentioned in the previous chapter (ovarian surface epithelium 
cells, oocytes, granulosa cells and theca cells) various somatic cell populations are expected to 
be found in human ovarian stroma. For example, endothelial cells fulfill important functions in 
the tissue as they contribute to blood vessel formation, which is crucial for follicle growth and 
atresia as well as for the formation of the corpus luteum after ovulation (Christenson et al., 
1996; Davis et al., 2003; Reeves, 1971; Suzuki et al., 1998b). In addition, perivascular cells, 
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including pericytes and smooth muscle cells, are needed where blood vessels are formed to 
stabilize endothelial cell structures and regulate blood flow (Wanjare et al., 2013). Lymphatic 
vessels are described to be part of the ovary’s vascular system, closely associated with the 
blood vasculature. These vessels are made up of lymphatic endothelial cells and smooth muscle 
cells and play a role in follicle development and wound healing (Brown et al., 2014). 
Furthermore, the ovary is innervated by extrinsic and intrinsic neurons which are hypothesized 
to have roles in ovary development, regulation of blood flow and follicle maturation (Anesetti 
et al., 2001). Mesenchymal stromal cells (MSCs) and immune cells are reported to support 
follicle growth and degeneration of the follicle after the oocyte has been ovulated, as well as 
facilitating closure and healing of the ruptured epithelial layer after ovulation (Bukulmez et al., 
2000; Ding et al., 2016a; Suzuki et al., 1998a). A recent single-cell report was the first to show 
the complexity of the different cell types found within the human medulla, including a variety 
of adaptive immune cells, such as T-cells, NK-cells, and B-cells, as well as innate immune 
cells, such as monocytes (Fan et al., 2019). Since the early 2000s, the existence of stem cell 
populations that have the potential to give rise to oocytes in the adult ovary is under continuous 
discussion. There are populations reported to have their origin in the cortex (putative oogonial 
stem cells) or in the surface epithelium of the ovary (very small embryonic-like cells, VSELCs). 
Their existence is still debated and will be elaborated in a later section. 
 
1.1.1 Human germ cell development 
Male and female germ cells, spermatozoa and oocytes, respectively, can fuse in the process of 
fertilization and give rise to a new human being. With the union of one oocyte and one 
spermatozoon, a zygote is formed which subsequently develops into a blastocyst that implants 
to the receptive uterine endometrium for further development. In the developing mouse 
embryo, the first primordial germ cells (PGCs, also referred to as fetal germ cells, or FGCs) 
can be identified shortly after implantation when they are being specified from a subpopulation 
of epiblast cells (Lawson et al., 1994). In humans, several hypotheses co-exist currently. 
Human PGCs may arise from the yolk sac endoderm, the extra-embryonic mesoderm or, like 
in mice and currently the most prominent hypothesis, from the posterior epiblast (Chen et al., 
2017) and were detected as early as week 4-5 of gestation (Tyser et al., 2020). Upon PGC 
specification in the human fetus, these cells reside within the primitive streak. They start 
proliferating and migrate to the gonadal ridge by week 6 of human gestation. At the gonadal 
ridge, PGCs continue to proliferate by mitosis, characteristically expressing among others 
PRDM14, POU5F1, NANOG and LIN28A (Li et al., 2017), before colonizing the fetal ovaries 
and differentiating into oogonia (Sarraj et al., 2012). The sexual fate of PGCs is not determined 
by its own constitution of sex chromosomes (XX or XY) but the constitution of the fetal gonad 
(Adams et al., 2002), hence migrating PGCs are not determined yet in their sexual identity but 
only upon arrival at the fetal ovary or testis. In the fetal ovary, PGCs are now termed oogonia. 
Here, they continue proliferating and form clusters of interconnected cells that become 
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enclosed by somatic cells in a structure called germ cell nests. During this differentiation 
process, oogonia become retinoic acid (RA) signaling-responsive, characterized by the 
expression of stimulated by retinoic acid gene 8 (STRA8), before entering meiosis (Li et al., 
2017). The ability to respond to RA signaling and hence initiate meiosis discriminates oogonia 
from spermatogonia. In fetal testes, the increased expression of CYP26B1 was reported to play 
a major role in quick degradation of RA to not yet initiate meiosis in spermatogonia (Bowles 
et al., 2006; Endo et al., 2019). By gestational week 9, oogonia express distinct germ cell 
markers, such as C-KIT, PRDM1, DDX4, DAZL, and SYCP3 (Eguizabal et al., 2016; Gomes 
Fernandes et al., 2018; Kerr et al., 2008). SYCP3, or synaptonemal complex protein 3, is a 
meiosis specific protein that enables oogonia to undergo meiosis. When meiosis is initiated 
around eleven to twelve weeks of gestation, oogonia are now termed oocytes, and the 
expression of pluripotency genes (e.g. POU5F1 and NANOG) is down-regulated (Anderson et 
al., 2007; Guo et al., 2015). By week 17, the majority of oogonia have entered meiosis. 
However, it has been reported that germ cells of different developmental stages (e.g. in mitotic, 
RA signaling-responsive, meiotic and oogenesis phase) co-exist in later stages of human 
embryo development. In an 18 weeks old fetus for example, all four stages of germ cells were 
found to be present (Guo et al., 2015; Li et al., 2017). Finally, oocytes become arrested in 
prophase I of meiosis I in dictyate stage when recombination of homologous chromosomes has 
occurred and chromosomes are still attached at chiasmata (Motta et al., 1997).  Lastly, germ 
cell nests containing several oocytes are infiltrated by the enclosing ovarian somatic cells 
around week 18, resulting in nest breakdown and the formation of the first primordial follicles 
as they appear in the post-natal ovary: a primordial follicle made up of one oocyte arrested in 
meiosis I, surrounded by flattened somatic epithelial granulosa cells (Tingen et al., 2009). 
Oocytes can remain in this stage for decades until they are activated, resume meiosis prior to 
ovulation and complete meiosis upon fertilization (Cohen et al., 2010; MacLennan et al., 2015).  
 
1.1.2 Folliculogenesis and the current dogma of limited female fertility 
In 1870, the anatomist and embryologist Waldeyer initially formulated the dogma of limited 
female fertility in humans due to a fixed ovarian follicle reserve established before birth 
(Waldeyer, 1870). Since then, researchers have been and still are investigating this 
phenomenon that is in stark contrast to the human male fertility with 200-300 million new 
spermatozoa being produced on a daily basis until death (Padubidri, 2011). Women exhaust 
their ovarian reserve on the average by 50-51 years of age and enter menopause (Faddy et al., 
1996; Faddy et al., 1992; Wallace et al., 2010), after which the chances of becoming a 
biological mother are lost. The dogma of a fixed follicle reserve is still considered valid: the 
human ovarian reserve is made up of millions of primordial follicles, established during 
embryo development and set before birth (Fakih, 2015). Already prenatally, a major fraction 
of those primordial follicles will start undergoing cell death, called follicle atresia, due to yet 
unknown reasons. Primordial follicle atresia is considered the main cause of constant 
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diminishing of the ovarian reserve throughout a woman´s life. In contrast, ovulation of mature 
oocytes consumes only a comparably small number of primordial follicles (Wallace et al., 
2010). Continuously throughout postnatal life, dormant primordial follicles are activated and 
recruited into the pool of growing follicles (McGee et al., 2000). Upon puberty, the HPG axis 
becomes active and gonadotropins are secreted allowing a fraction of the recruited follicles to 
further mature. During folliculogenesis, the follicle grows in size from around 30 μm to 20 mm 
(Fig.1A) with the oocyte reaching 120 μm at the time of ovulation (van den Hurk et al., 2005).  
 
Histologically, developmental stages of follicles have been well characterized (Gougeon, 1996) 
(Fig.1A). When primordial follicles (Fig.1C) are activated, flattened somatic pre-granulosa 
cells surrounding the immature oocyte become cuboidal while transitioning through the stage 
of an intermediary follicle (Fig.1D.). When surrounded by a full layer of cuboidal cells, the 
follicle is called a primary follicle (Fig.1E). These cuboidal granulosa cells proliferate to form 
a multi-layered secondary follicle (Fig.1F, G). An antrum is formed in the follicle that expands. 
Theca cells differentiate and align around the follicle to further support follicle maturation until 
the oocyte reaches its final state of maturation in the antral follicle. This process is called 
folliculogenesis, the maturation of the primordial follicle to the ovulated oocyte.  
 
Although some pathways were discovered to play crucial roles in primordial follicle activation, 
the exact molecular mechanisms and interplays of involved genes are still elusive. The 
PI3K/AKT signaling pathway (Fig.3) was found to be involved by several independent 
research groups using genetically modified mouse models (Adhikari et al., 2009b; Reddy et al., 
2008; Reddy et al., 2010; Zhang et al., 2014) and suspected to be equally important in bovine 
(Andrade et al., 2017) and human (Grosbois et al., 2018; Kawamura et al., 2013). It is to date 
the best studied mechanism in the mammalian ovary. Briefly, the phosphoinositide 3-kinase 
(PI3K) is negatively regulated by PTEN when the follicle is arrested in its dormant state. Upon 
binding of different ligands (e.g. KITL, Insulin) to their respective receptors (e.g. C-KIT) on 
the oocyte, the PI3K pathway is activated and elicits a cascade of phosphorylation of various 
proteins, among them AKT which phosphorylates TSC1/2 (tuberin/tuberous sclerosis complex 
1 and 2). Phosphorylated TSC1/2 is inactive and cannot inhibit Rheb protein any longer which, 
subsequently, leads to mTORC1 activation. Activated mTORC1, or mammalian target of 
rapamycin complex 1, can phosphorylate S6K, a ribosomal protein kinase, which in turn 
phosphorylates the ribosomal protein rpS6. RpS6 initiates the synthesis of proteins involved in 
cellular survival and growth. It was shown in mice that the deletion of TSC1/2 in oocytes of 
primordial follicles leads to a premature depletion of the ovarian reserve (Adhikari et al., 2009a; 
Adhikari et al., 2010). Another target of AKT is FOXO3A. FOXO3A is usually residing in the 
cell nucleus acting as a transcriptional activator, assuring oocyte dormancy. Upon 
phosphorylation, FOXO3A translocates to the cytoplasm and consequently, cannot function as 
a transcription factor anymore. Studies using transgenic mouse models reveal a massive 
activation of primordial follicles when FOXO3A is depleted (Castrillon et al., 2003) and vice 
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versa, an inhibition of oocyte growth when FOXO3A is constitutively expressed (Liu et al., 
2007). These studies indicate the important role of FOXO3A, its phosphorylation status and 
localization, in the initial recruitment of dormant follicles into the pool of actively growing 
follicles. Additionally, the Hippo pathway was shown to be involved in follicle activation in 
vitro. Upon fragmentation of the ovarian cortex, Hippo signaling is disrupted which allows 
YAP to act as co-activator in the nucleus. Transcriptional activation of downstream targets, 
such as CCN growth factors, promotes follicular activation and growth (Grosbois et al., 2018; 
Kawamura et al., 2013). In human, a combination of PI3K stimulation and Hippo disruption 
by ovarian cortex fragmentation was used for treatment of patients suffering from premature 
ovarian insufficiency which led to successful pregnancy and live birth (Kawamura et al., 2013).  
 
In mice, the existence of sub-populations of primordial follicles was reported (Zheng et al., 
2014) with the “first wave” being immediately activated postnatally after they are formed and 
possibly responsible for induction of puberty onset and early fertility. In contrast, the adult 
“second wave” follicles are being activated gradually and supply follicles throughout 
adulthood. Based on this, a potential model of two distinct waves of primordial follicles was 
hypothesized to also apply to humans. This might explain morphological differences in 
primordial follicle structures found in pre-pubertal ovaries as compared to adult ovaries. 
Anderson et al. described morphologically abnormal non-growing follicles present to a high 
extent in the pre-pubertal ovaries. As this population showed a limited capacity for in vitro 
growth and are reduced in pubertal and absent in adult ovaries, they may potentially represent 
the “first wave” follicles described in mice (Anderson et al., 2014). 
 
Taken together, a primordial follicle formed during human embryo development has three 
potential fates postnatally: death through atresia, arrest in a dormant state mediated through 
repressive signals (e.g. PTEN, FOXO3A) or its transition into a growing state upon activating 
signals (KITL, growth factors) (Tingen et al., 2009). Even though a lot of progress has been 
made during the last couple of years, especially driven by mouse studies, in-depth studies on 
the molecular mechanisms underlying the fate determination of primordial follicles are clearly 
missing.  
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Fig.3 The PI3K/AKT signaling pathway is involved in primordial follicle activation. In the oocyte 
of a dormant follicle (upper diagram), PI3K is inhibited by PTEN which keeps FOXO3A 
unphosphorylated. Unphosphorylated FOXO3A is located in the nucleus where it can act as a 
transcriptional activator. Upon follicle activation (lower diagram), e.g. KITL from the granulosa cells 
binds to the C-KIT receptor on the oocyte, PI3K elicits a phosphorylation cascade. AKT kinase is 
phosphorylated which in turn phosphorylates FOXO3A. Phosphorylated FOXO3A translocates into the 
cytoplasm and cannot fulfil its function as a transcription factor any longer. In addition, TSC1/2 is 
inhibited and cannot act as inhibitor of Rheb. This activates mTORC1 which ultimately leads to 
activation of rpS6 and protein synthesis. Graphics was created using ©BioRender. 
 
1.1.3 Ovarian aging and menopause 
A woman enters menopause when the ovarian reserve is consumed to a level where around 
1,000 follicles or less remain (Faddy et al., 1996; Faddy et al., 1992). On average, this is around 
the age of 50-51 years but was reported to depend on the size of the primordial follicle 
population at its peak during embryo development at 18-22 weeks of gestation (Wallace et al., 
2010). A lower prenatal peak number of primordial follicles correlates with an early menopause 
onset and vice versa. Menopause is defined by amenorrhea for at least one year. On a 
physiological level, menopause reveals itself in the loss of the ability to conceive, a disturbed 
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thermoregulation (“hot flushes”), cardiovascular diseases and osteoporosis, among others 
(Davis et al., 2015). On an endocrine level, changes in the hormonal profile are observed, such 
as elevated FSH levels and reduced concentrations of estrogen and AMH. Serum AMH levels 
is a widely used biomarker to determine the size of the ovarian reserve and to predict the 
reproductive lifespan. Growing follicles (from secondary follicle stage onwards) secrete AMH 
and the growing follicle population was suggested to also be reflective of the non-growing 
follicle population, hence the ovarian reserve. After a peak of serum AMH levels around 24-
25 years, levels decline with age (Kelsey et al., 2011). Ovarian aging was also found to correlate 
with an increasing collagen deposition in the ovarian stroma (Motta et al., 2002; Ouni et al., 
2020). While elastic fibers decrease, the more stiff collagen fiber content increases and was 
suggested as contributing factor to menopause onset (Ouni et al., 2020). On a molecular level, 
changes in the ovary proceeding menopause onset are less known. However, a recent study on 
ovary aging in non-human primates suggested oxidative stress as a key player (Wang et al., 
2020). The subsequent analysis of human granulosa cells suggested similar mechanisms at play 
during the process of human ovarian aging: granulosa cells isolated from follicular fluid 
showed an aging associated decrease in antioxidant activity and an increase in oxidative stress 
induced damage (Wang et al., 2020). 
 
Age is a natural cause of menopause. However, early onset of menopause can be caused by 
premature ovarian insufficiency. The origins of premature ovarian insufficiency are manifold, 
including diabetes mellitus, autoimmune disorders, polycystic ovarian syndrome and chemical 
insults like smoking and anti-cancer treatment. 
 
1.2 FERTILITY RELATED EFFECTS OF ANTI-CANCER THERAPY 
Anti-cancer treatment improves constantly by early diagnoses and availability of more 
selective therapies, leading to a drastically increasing survival rate of patients (Siegel et al., 
2017; Trama et al., 2019). Chemo- and radiotherapy damages ovarian follicles, with alkylating 
(e.g. cyclophosphamide and busulfan) and alkylator-like chemotherapy agents (e.g. cisplatin) 
being considered most detrimental (Morgan et al., 2012; Oktem et al., 2008) and recent studies 
show that adult patients cured from cancer of all types are 38% less likely to conceive 
(Anderson et al., 2018). Classically, rapidly proliferating cells (such as granulosa cells in a 
growing follicle) are targeted by cell-cycle specific chemotherapy drugs, such as 
antimetabolites (Yuksel et al., 2015), causing DNA adducts and DNA damage (see Fig.4). In 
contrast, many alkylating agents and anthracyclines used for chemotherapy treatment, such as 
cyclophosphamide and doxorubicin, respectively, are cell-cycle unspecific and hence, can 
affect primordial follicles in their dormant state (see Fig.4). Either way, the induction of DNA 
damage can ultimately lead to double strand breaks (DSBs) which initiates a so-called DNA 
damage response mechanism within the cell which – in its most deadly form – triggers cell 
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apoptosis. DSBs are also the most common form of DNA damage induced by irradiation 
(Thompson, 2012). 
 
As chemotherapy treatment most often combines a plethora of different drugs, the risk of 
infertility is usually estimated based on the type of malignant disease and its associated 
treatment regimen (Wallace et al., 2005). For example, chemotherapy and radiation treatments 
of Hodgkin’s disease as well as conditioning therapies for hematopoietic stem cell 
transplantation (HSCT) patients are associated with a very high risk (>80%) of subfertility after 
successful treatment through premature ovarian insufficiency at all ages (Meirow et al., 2001; 
Wallace et al., 2005; Warne et al., 1973). Premature ovarian insufficiency patients show the 
above mentioned menopausal symptoms at ages younger than 40 years, including an exhausted 
ovarian reserve, decreased pregnancy rate and hormonal imbalances, such as high serum levels 
of FSH, low levels of estrogens and decreased serum levels of AMH (Green et al., 2009; van 
Dorp et al., 2016; van Kasteren et al., 1999).  
Adverse effects of chemotherapy on ovaries was reported to increase with age. The older the 
patient – hence, the smaller the remaining ovarian reserve – at the time of treatment, the more 
likely they will experience ovarian failure afterwards (Meirow et al., 2001).  
 
Despite great progress in the field, the molecular mechanisms involved in anti-cancer 
treatment-triggered depletion of the ovarian reserve and its downstream effect on hormonal 
imbalances have not yet been fully unraveled. Potential targets of chemotherapy treatment 
within the ovarian follicle are both oocyte and granulosa cells as well as the stromal 
compartment including the vascular system of the ovary. Research in this field has mainly 
focused on the effect of anti-cancer treatment on ovarian follicles and currently suggests two 
main mechanisms, addressed in more detail below: “burnout” of the ovarian reserve through 
an over-activation of primordial follicles and follicle death induced by DNA damage.  
 
1.2.1 “Burnout hypothesis” 
The detrimental effect of chemotherapy on fertility is partly caused by destruction of the 
somatic cells of growing follicles. Proliferating, somatic ovarian cells are the first target of 
chemotherapy agents. Theca cells and granulosa cells are among the most active cell types in 
the ovary. As discussed earlier and depicted in Fig.2, these cells play a major role in the 
production of steroid hormones and growth factors in the ovary and once undergoing 
chemotherapy-induced apoptosis, the steroidogenic pathway and signaling network via local 
growth factors, e.g. AMH, is affected (Cohen, 2008; Yuksel et al., 2015). AMH is expressed 
in granulosa cells of growing follicles and inhibits initial follicle recruitment via negative 
feedback (Dumont et al., 2015).  
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This rationale of chemotherapy induced disruption of negative feedback signaling in the ovary 
led Prof. Meirow´s group to formulate the “burnout hypothesis” (Kalich-Philosoph et al., 2013; 
Meirow et al., 2010). This group studied the effect of cyclophosphamide in mice and their 
hypothesis also resonated with researchers studying chemotherapy effects on the bovine 
(Gavish et al., 2015) and human ovary (Gavish et al., 2015; Lande et al., 2017). Proliferating 
cells, including granulosa cells of growing follicles, are destroyed by chemotherapy (Lopez et 
al., 2004) which leads to an activation of dormant follicles due to the missing negative cues, 
such as AMH (Durlinger et al., 2002). Prof. Meirow’s group observed this increased follicle 
activation through PI3K/AKT signaling and concluded that the ovarian reserve burns out 
prematurely due to an increased recruitment of primordial follicles into the pool of growing 
follicles (Kalich-Philosoph et al., 2013) (see Fig.4).   
  
1.2.2 DNA damage induced follicle death 
DSBs are another phenomenon through which chemotherapy-induced damage of ovarian 
follicles can occur (see Fig.4). DSBs introduced by chemotherapy agents can be handled in two 
ways: the oocyte resolves those DSBs by either repair or death. Primordial follicles in the 
mouse and human ovary were shown to be able to repair DSBs to some extent (Winship et al., 
2018). However, when damage cannot be repaired, oocyte death is mediated via apoptosis. It 
was shown in a xenograft model that a single dose of cyclophosphamide results in significant 
loss of primordial follicles in human ovarian tissue through the mechanism of apoptosis (Oktem 
et al., 2007a). 
 
TAp63 was identified as the key mediator of apoptosis in ovarian follicles upon anti-cancer 
treatment (Kerr et al., 2012). TAp63 is a p53 family member transcription factor, highly 
conserved in mammals and specifically expressed in the female germline (Gonfloni et al., 2009; 
Levine et al., 2011; Soleimani et al., 2011a; Suh et al., 2006). TAp63 activates the pro-apoptotic 
protein p53 upregulated modulator of apoptosis (PUMA) which mediates induction of 
apoptosis. The mechanism of apoptosis induction in follicles upon chemotherapy treatment 
was elegantly proven in mice (Nguyen et al., 2018). Chemotherapy treated 
Puma−/− mice showed full retention of primordial follicles by repair of induced DSBs, while 
primordial follicle reserve was reduced down to 4% in chemotherapy treated wildtype mice. 
As rescued primordial follicles could contribute to healthy reproduction, the authors suggested 
the inhibition of PUMA as ovary-protective treatment in women undergoing chemotherapy to 
preserve the ovarian reserve (Nguyen et al., 2018). 
 
Along those lines, LH was recently suggested as another ovo-protective agent as it was found 
to preserve the ovarian reserve in pre-pubertal mice undergoing chemotherapy treatment using 
cisplatin (Rossi et al., 2017). The mechanism behind this protective effect is potentially 
mediated through the observed increase in anti-apoptotic signals generated by LHR expressing 
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somatic cells. Anti-apoptotic signals led to lower levels of TAp63 and an overall nudge towards 
DSB repair rather than apoptosis of the ovarian reserve follicles. However, it is not fully 
understood yet which somatic cells would mediate this anti-apoptotic effect via LHR in the 
prepubertal ovary and warrants deeper investigation. 
 
Bedoschi et al. carefully reviewed the data published on chemotherapy induced follicle loss 
and concluded that the data available to support the “burnout hypothesis” are insufficient yet 
while “…the evidence for DNA damage induced follicle death is highly convincing …” 
(Bedoschi et al., 2016).  
 
1.2.3 Chemotherapy effect on the stromal compartment of the ovary 
Studies show that ovarian follicles are also likely to be damaged more indirectly via detrimental 
effects of anti-cancer treatment on the stromal compartment in the ovary. The ovarian stroma 
is highly vascularized by several factors including blood and nutrient supply to growing 
follicles. Several histological studies on ovarian tissue sections from pre- and post-pubertal 
cancer patients reported the increased appearance of fibrosis and an altered structure of the 
vasculature. They describe a higher prevalence of fibrotic areas as well as vessel thickening 
(Marcello et al., 1990; Meirow et al., 2007; Nicosia et al., 1985), lower levels of neo-
angiogenesis along with lower density of mature blood vessels (Soleimani et al., 2011a), 
possibly explaining the lower blood flow observed in chemotherapy-exposed ovarian tissue 
(Ben-Aharon et al., 2012) (see Fig.4). Although it has long been believed that dormant, 
primordial follicles – in contrast to growing follicles – do not depend on vascularization, an 
inverse correlation was shown between vascular density and the percentage of atretic 
primordial follicles in xeno-transplanted human ovarian tissue (Soleimani et al., 2011b). In 
other words, (neo-)vascularization seems to be required for the survival of even dormant 
follicles. However, to this date, the connection of altered stroma/vasculature and ovarian 
follicle quality has not been studied on a molecular level. And it remains speculative how 
exactly a damaged ovarian stroma with increased fibrosis and altered vasculature would affect 
the ovarian follicle reserve and/or ovarian follicle development.  
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Fig.4. Potential effects of chemotherapy on the human ovary. Chemotherapy treatment was reported 
to impair the ovarian follicles via different routes: directly via induction of DNA damage into dormant 
and growing follicles and/or indirectly via a premature depletion of the ovarian reserve, an altered 
vasculature, and fibrotic lesions. Premature depletion of the ovarian reserve based on the “burnout 
hypothesis” suggests that AMH-mediated inhibition of primordial follicles goes missing upon apoptosis 
of growing follicles, thereby accelerating primordial follicle activation and depletion of the ovarian 
reserve. Graphics was created using ©BioRender. 
 
1.2.4 Fertility treatment options for cancer survivors 
Ultimately, unravelling the mechanisms behind chemotherapy-induced follicle loss serves to 
develop a strategy to prevent the depletion of the ovarian reserve and maintain the integrity and 
quality of follicles in order to preserve future fertility of the patient. So far, the only two 
treatment options for patients at high risk of future infertility due to treatments are fertility 
preservation through cryopreservation of embryos/oocytes or ovarian tissue. Embryo and 
oocyte cryopreservation are established interventions but can only be offered to post-pubertal 
and adult patients as it requires the availability of mature oocytes. The cryopreserved embryo 
or oocyte can be thawed for standard fertility treatments through IVF and embryo transfer after 
recovery of the patient (Donnez et al., 2017). 
 
For pre-pubertal cancer patients in very high risk of future infertility and patients that cannot 
delay chemotherapy onset, autologous ovarian tissue cryopreservation is considered the only 
alternative. In theory, one can preserve thousands of primordial follicles at once with this 
Oocyte Oogonial stem cell 
C 
N 
DDX4 Ab 
DDX4 Ab+ DDX4 Ab- 
In vitro cultur  
Human ovarian cortex 
GFP transfection 
Intra-ovarian injection 
Human OSCs Mouse OSCs 
Xenografting Follicle formation Live offspring 
Isolated OSCs 
Extraction of mitochondria 
3. ICSI and 
mitochondria injection 
2. Oocyte retrieval 
1. Ovaria
n cortex
 biopsy 
4. Embryo transfer 
Embryo culture 
PGCs ? 
Epiblast 
Hypoblast 
Week 2 
altered 
vasculature 
direct loss of 
dormant follicles 
direct loss of 
growing follicles 
stromal damage / 
fibrosis 
primord
ial 
sec
ond
ary 
prim
ary 
antral 
accelerated 
activation 
AM
H  
Hypothalamus 
Anterior 
pituitary 
Ovary 
GnRH 
LH and FSH 
Androgen, estrogen and 
progesterone 
 14 
procedure. Transplantation of frozen/thawed ovarian tissue (Ovarian Tissue Transplantation, 
OTT) has been proven successful for adult women and more than 130 live births have been 
reported up to date (Donnez et al., 2017). Cohort studies showed that in adults, OTT of ovarian 
tissue exposed to chemotherapy agents prior to cryopreservation results in similar rates of 
endocrine function, pregnancy and live births when compared to OTT with unexposed ovarian 
tissue (Meirow et al., 2016; Poirot et al., 2019). Case reports documented that OTT following 
ovarian tissue cryopreservation in pediatric patients was used to induce puberty in two patients 
(Ernst et al., 2013; Poirot et al., 2012) and successful pregnancy could be achieved after 
transplantation of cryopreserved ovarian tissue harvested at an age of thirteen and nine years, 
respectively (Demeestere et al., 2015; Matthews et al., 2018). It is uncertain whether these two 
patients classified as pre-pubertal at the time of ovarian tissue cryopreservation. Even though 
the patients were pre-menarche, hormone levels and breast development indicated puberty 
onset in the case of the thirteen-year-old girl and were not documented for the nine-year-old 
girl.  
 
Since last year, OTT in pediatric patients is no longer considered experimental by the American 
Society for Reproductive Medicine (ASRM, 2019). However, as highlighted by the Pediatric 
Initiative Network in a response letter, ovarian tissue cryopreservation research needs to be 
continued as risks and benefits are not fully understood in the pediatric population (Nahata et 
al., 2020). Valuable concerns regarding follicle quality in transplanted tissue of young patients 
have been raised. In young patients, it was suggested that a younger age (children versus young 
adolescents) protects against chemotherapy-induced infertility due to the bigger ovarian 
reserve (El Issaoui et al., 2016). However, in human in vitro studies, morphological 
abnormalities and reduced developmental potential was reported for primordial follicles 
(Anderson et al., 2014; Asadi Azarbaijani et al., 2015) and oocytes of primordial follicles (Abir 
et al., 2016) of pre-pubertal ovaries, independent of chemotherapy treatment. This could 
suggest that follicles from young girls are more fragile compared to adults and would support 
the hypothesis of two waves of primordial follicles in the human ovary (Anderson et al., 2014).  
Ideally, ovarian tissue cryopreservation should be done before chemotherapy onset due to the 
gonadotoxic effects elaborated in the previous sections. However, this might not be feasible in 
cases when immediate treatment onset is necessary, when first-line chemotherapy appears 
ineffective and more intensive treatment is required or when patients relapse (Wallace et al., 
2016). Selection criteria of pre-pubertal patients to be offered ovarian tissue cryopreservation 
are not fully harmonized among different centers. According to the recommendations 
established by the Nordic Society for Pediatric Hematology and Oncology (NOPHO 2013), in 
the Nordic countries (Sweden, Finland, Norway, Denmark and Iceland), only pre-pubertal 
patients who are receiving anti-cancer treatment associated with a very high risk of POI can be 
referred to fertility preservation through ovarian tissue cryopreservation. Very-high risk 
treatments include conditioning therapies for allogenic or autologous hematopoietic stem cell 
transplantation or radiotherapy in the ovary field. However, as mentioned above, patients might 
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only fall into the very high-risk group after initial ineffective first-line chemotherapy treatment 
with agents of a lower risk group. In these cases, ovarian tissue cryopreservation is performed 
with ovarian tissue exposed to (first-line) chemotherapy agents. 
 
Of note, another concern is the re-introduction of malignant cancer cells upon transplantation 
of cryopreserved ovarian tissue harvested prior to chemotherapy treatment. This particularly 
concerns certain cancer types, such as leukemia (Dolmans et al., 2010). Therefore, only patients 
with a low risk of ovarian metastatic cells are considered for OTT (Dolmans et al., 2013), 
further restricting the patient group that could benefit from current fertility preservation 
options. Although latest advances in ovarian tissue cryopreservation have improved the success 
rate of female fertility preservation tremendously (Anderson et al., 2017; Oktay et al., 2018), 
data on the safety and efficacy after ovarian tissue cryopreservation are still limited. 
Furthermore, molecular mechanisms of follicle loss through cytotoxic agents are still not fully 
understood and remain to be identified. 
 
ABVD-type chemotherapy is commonly used to treat Hodgkin’s lymphoma and is composed 
of the chemotherapeutic drugs adriamycin, bleomycin, vinblastine and dacarbazine. ABVD 
treatment is considered low risk in terms of infertility (Hodgson et al., 2007). Quite the 
contrary, following this treatment, a surprising increase in the amount of dormant, non-growing 
follicles was observed in the tissue of pediatric and young adult patients when compared with 
age-matched predicted values (McLaughlin et al., 2017). The underlying mechanism of this 
observed phenomena is not understood. One proposed explanation is the activation of tissue 
resident stem cells which might have the capacity to differentiate into new oocytes, thereby 
regenerating the pool of dormant follicles upon this specific chemotherapy treatment 
(McLaughlin et al., 2017).  
 
1.3 OOGONIAL STEM CELLS IN THE ADULT OVARY 
The dogma of a fixed ovarian reserve in mammals has long been debated. Latest reports in 
ovarian research brought up the possibility of an existing germline stem cell population (also 
and from now on termed oogonial stem cells, OSCs) in the adult mammalian ovary (Johnson 
et al., 2004; White et al., 2012; Zou et al., 2009). OSCs were reported to have the potential to 
differentiate into oocytes and hence, to hold great potential for the treatment of infertility or 
chemotherapy-induced premature ovarian insufficiency. 
 
It is well-known that some non-mammalian species harbor germline stem cells in the adult 
ovary. In invertebrates, e.g. the fly Drosophila and the nematode Caenorhabditis elegans (C. 
elegans), oocytes are consistently being produced through germline stem cell differentiation in 
the adult ovary. In Drosophila, germline stem cells are sitting at the tip of each ovary (termed 
ovariole) in a niche comprised of three somatic supporter cell types. Germline stem cells divide 
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asymmetrically assuring that the germline niche does not exceed the size of approximately two 
germline stem cells (Spradling et al., 2011). In C. elegans, the Distal Tip Cell located at the 
distal tip of the gonads is maintaining a stable pool of germline stem cells that ensures the stable 
production of gametes in the adult worm (Kimble et al., 2008). However, non-mammalian 
vertebrate models, such as zebrafish (Danio rerio) and frog (Xenopus leavis), are less studied 
and no solid conclusions regarding the presence of germline stem cells in their postnatal ovary 
have been reached yet. 
 
In mammalian species, the dogma of a fixed ovarian reserve and hence the absence of female 
germline stem cells in the postnatal ovary was challenged in 2004 when the research group of 
Prof. Tilly reported the existence of OSCs in adult mouse ovary (Johnson et al., 2004) and eight 
years later in adult human ovary (White et al., 2012). In the initial mouse study (Johnson et al., 
2004), the authors investigated follicle degeneration from birth until entry into reproductive 
senescence. They found that the ovarian reserve should be depleted much earlier than reported 
before (Faddy et al., 1987) when taking into account the observed rate of follicle degeneration 
and concluded that neo-oogenesis takes place in the postnatal mouse ovary. Indeed, when 
evaluating the ovary morphologically, they found large ovoid cells in the surface epithelium 
that resembled germ cells and expressed the germline marker DDX4 (DEAD-box polypeptide 
4) at the protein level and the proliferation marker BrdU (5-bromodeoxyuridine). Those large 
ovoid cells were suggested to be OSCs. In a follow-up study, they documented that OSCs might 
originate from bone marrow and peripheral blood (Johnson et al., 2005). This was hypothesized 
from the fact that PGCs and hematopoietic cells originate in the same region during 
embryogenesis (Ratajczak, 2017). 
Subsequently, Tilly’s group established a protocol to study OSCs from mouse ovaries (Zou et 
al., 2009). For this, OSCs were isolated by magnetic-activated cell sorting (MACS) using a 
specific antibody directed against the C-terminal domain of the germ cell marker DDX4 
(Fig.5). OSCs from adult mouse ovaries could be isolated and cultured long-term, and they 
gave rise to viable offspring when transplanted into ovaries of infertile mice (Zou et al., 2009).  
 
 
Fig.5. Cellular localization of DDX4 
in the mouse and human ovary 
based on OSC hypothesis. While the 
oocyte is known to express DDX4 
protein in the cytoplasm throughout all 
developmental stages (Castrillon et al., 
2000), the C-terminal domain of 
DDX4 in OSCs was reported to have 
an extracellular epitope (White et al., 
2012). Graphics was created using 
©BioRender. 
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This protocol using MACS was modified to the usage of fluorescence-activated cell sorting 
(FACS) when OSCs in mouse and human adult ovary were reported, yielding in a higher purity 
of the population of interest (White et al., 2012). This small population of DDX4 antibody 
(Ab)-positive cells (around 1.7% in human and 1.5% in mouse) was shown to express germ 
cell markers (PRDM1 and C-KIT) on a transcriptional level and to grow in size when cultured 
in vitro. When these putative human OSCs were GFP-labelled and injected into human ovarian 
cortex and further xeno-transplanted into mouse ovaries, big green fluorescing cells (potentially 
human oocytes) were found being surrounded by smaller non-fluorescent cells (potentially 
mouse granulosa cells) after one week (Fig.6). Based on these findings, the authors concluded 
that cells isolated with the DDX4 antibody comprise germline stem cell characteristics with the 
potential to differentiate into oocytes in vivo. 
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Fig.6. Published isolation protocol of OSCs (Woods et al., 2013). DDX4 Ab is used for sorting of 
DDX4 Ab-positive and Ab-negative populations. Sorted DDX4 Ab-positive cells were cultured under 
OSC conditions in vitro and transduced with GFP vector. GFP-expressing mouse OSCs were injected 
into mouse ovaries and viable, GFP-positive offspring was generated. GFP-expressing human OSCs 
were injected into human ovarian cortex and xeno-grafted under the skin of immunodeficient adult mice. 
Formation and maturation of GFP-positive oocytes was observed after one week of transplantation. 
Graphics based on Woods and Tilly 2013 with permission and created using ©BioRender. 
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1.3.1 The role of DDX4 in the germ cell lineage 
DDX4 as a germline marker is a universal and highly conserved member of the DEAD box 
protein family and, just like DAZL, an RNA-binding protein. While their specific functions are 
not fully understood yet, both are known to play a role in protein stabilization and localization 
during PGC formation and considered crucial drivers of germ cell determination (Nicholls et 
al., 2019; Smorag et al., 2014). In vitro studies on human PGCs and murine in vivo and in vitro 
studies indicate that DAZL is operating upstream of DDX4, reporting an upregulation of DDX4 
upon DAZL overexpression – but not vice versa (Canovas et al., 2017) – probably due to 
translational regulation of DDX4 through DAZL (Reynolds et al., 2005). 
 
DDX4 protein is an ATP-dependent RNA helicase (Castrillon et al., 2000) and based on its 
protein conformation as well as on experimental and in silico data, DDX4 is considered to be 
a cytoplasmic protein (Zarate-Garcia et al., 2016). Experimental data however are contradictive 
with studies reporting DDX4 localization to be restricted to the cytoplasm (Fujiwara et al., 
1994; Nott et al., 2015) but also to be found on surface of transfected human embryonic kidney 
(HEK) 293T cells (Clarkson et al., 2019). It’s been believed to be exclusively expressed in the 
germline from around week 7 of human gestation onwards and maintained throughout 
development and differentiation of oogonia into oocytes of primordial follicles (Castrillon et 
al., 2000; Dorfman et al., 1999) (Fig.5). Similarly, in fetal testis, DDX4 can be detected intra-
cytoplasmically in spermatocytes and spermatogonia. 
 
DDX4 was first identified in Drosophila melanogaster (named Vasa in Drosophila) where it 
is regulating translation of mRNA expression during germ cell development (Hay et al., 1988). 
Vasa null mutations were reported to lead to female – but not male – sterility in Drosophila, 
whereas homozygous mutations, with partially remaining Vasa function, allow formation of 
embryos which lack germ cells (Schupbach et al., 1986).  
In contrast, mice show a pronounced effect on male fertility when DDX4 (also called Mouse 
vasa homolog, MvH) is mutated: male homozygous mutants are sterile, while female mice 
don’t show any reproductive abnormalities and remain fertile (Tanaka et al., 2000).  
Although the crucial role of DDX4 during PGC determination would suggest it, so far, no 
findings have yet been reported that would link DDX4 mutations to fertility-related problems 
in humans.  
 
1.3.2 Attempts to validate the existence of OSCs in human adult ovaries 
As all potential shifts in paradigm, Tilly´s work was highly criticized. Follow-up research on 
putative OSCs in mouse and human postnatal ovary by other groups presented conflicting 
results. In this section, I will focus on studies investigating putative OSCs in adult human ovary 
only.  
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The method used to isolate putative OSCs heavily relies on a polyclonal Ab directed against 
the C-terminal domain of DDX4 protein (Woods et al., 2013). As mentioned above, DDX4 
protein is considered to be expressed in the cell cytoplasm in vivo. This would not allow an 
isolation of viable OSCs by FACS which is a technology that requires extracellular proteins as 
targets. However, some studies suggest that OSCs display a surface epitope of DDX4 C-
terminus that can be used to target this cell population (Woods et al., 2013) (Fig.5).  
 
Reproducibility of the data reported by Prof. Tilly´s group has been challenging. Although all 
groups, including our laboratory, demonstrate the successful isolation of cells from the human 
ovary using the same DDX4 Ab (ab13840 from Abcam), their abundancy is varying among 
different studies, ranging from 2.5 – 24% (Hernandez et al., 2015; Zarate-Garcia et al., 2016; 
Zhang et al., 2015) as compared to 1.7% initially documented by Tilly (White et al., 2012). In 
addition, while some groups were able to detect DDX4 mRNA in freshly isolated DDX4 Ab-
positive cells (Clarkson et al., 2018; Ding et al., 2016b; White et al., 2012), others were not – 
neither by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) (Hernandez 
et al., 2015; Zarate-Garcia et al., 2016; Zhang et al., 2015), nor by single-cell mRNA 
sequencing (scRNA-seq) (Zhang et al., 2015). Mass-spectrometry analysis did not detect 
DDX4 protein either, although cells were isolated based on detection of DDX4 by DDX4 Ab 
using FACS (Hernandez et al., 2015). The authors of these studies concluded that DDX4 Ab 
might bind to unspecific surface epitopes and that the DDX4 Ab-positive cells do not actually 
express DDX4 (Hernandez et al., 2015; Zarate-Garcia et al., 2016; Zhang et al., 2015). 
Boellaard et al. specifically investigated whether a positive signal for DDX4 by 
immunostaining is sufficient to identify germ cells in male urogenital tissue and concluded that 
immunocytochemistry with different DDX4 Abs (among those the Ab used in the OSC 
isolation protocol) is unspecific compared to mRNA evaluation. Hence, only transcriptome-
based results are indicative of DDX4 expression and should be used for germ cell detection 
(Boellaard et al., 2017).  
 
Many lines of evidence suggest that the DDX4 Ab-based OSC isolation protocol is not specific 
and may yield a heterogeneous mixture of cell types. This was recently confirmed by Prof. 
Telfer’s group, who investigated molecular characteristics of DDX4 Ab-positive cells from 
human ovaries isolated with the DDX4 Ab-based FACS protocol. Three distinct DDX4 Ab-
positive populations in ovarian cortex cell suspension were found that differ in size, aldehyde 
dehydrogenase 1 (ALDH1) activity, and a different expression pattern of DDX4 splice variants 
and of DAZL. Furthermore, they show that this heterogeneous DDX4 Ab-positive cell 
population can form follicle-like structures in a fetal somatic cell environment (Clarkson et al., 
2018).  
 
Besides the already mentioned widely criticized use of DDX4 Ab for OSC isolation, the OSC 
isolation protocol comes with several technical challenges. Issues such as ovarian tissue source, 
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handling, digestion into single cells and Ab labeling can differ slightly among different 
laboratories. Gating strategies for FACS based isolation of OSCs are rarely reported but is a 
crucial step prone to inconsistencies when cell populations are sorted by different operators. 
As frequently brought up in discussions around OSCs, all this can have a great impact on cell 
yield, viability and detection of small sub-populations (Woods et al., 2013, 2015b). And finally, 
lot-to-lot differences in enzymes and the polyclonal DDX4 antibody recommended for OSC 
isolation have been reported to impact the detection and purity of the final product (Woods et 
al., 2013). Of note, centrifugation speed of the obtained ovarian single cell suspension was also 
deemed crucial when isolating stem cell populations from ovarian tissue (Bhartiya et al., 2020). 
Slight methodological divergence between different groups might hence explain the 
inconsistencies found in literature with regards to nature and characteristics of isolated DDX4 
Ab-positive cells. Clearly, the published protocols for isolation of OSCs must contain more 
detail in order to ensure successful isolation of these cells across laboratories. 
 
In addition to the reports of putative OSCs in adult human ovarian cortex, some research groups 
have postulated the existence of a cell population with pluripotency potential in the adult human 
ovarian surface epithelium. Those so-called very small embryonic-like cells (VSELCs) were 
found to express the pluripotency markers POU5F1, SSEA-4, NANOG, SOX2 (shown by 
qPCR and immunocytochemistry) as well as DDX4 using immunocytochemistry (Parte et al., 
2011; Stimpfel et al., 2013; Virant-Klun et al., 2013b). It is unknown yet whether VSELCs and 
OSCs co-exist in the human ovary or if – as suggested by the authors of VSELC studies 
(Bhartiya et al., 2018; Virant-Klun et al., 2013a) – VSELCs might be the precursor cells giving 
rise to OSCs.  
 
1.3.3 Clinical relevance of OSCs 
The discovery of putative OSCs in the adult human ovary has reached the media at an early 
stage and raised big hopes among clinicians and their female patients facing infertility. In 2011, 
the company OvaScienceSM was founded that offers fertility treatments based on DDX4 Ab-
positive putative OSCs at selected clinics. The first treatment launched, called AUGMENTSM 
(Autologous Germline Mitochondrial Energy Transfer, Fig.7), involves the isolation of DDX4 
Ab-positive cells from a biopsied sample of ovarian cortex of the patient. The isolated cells are 
cryopreserved and when needed, thawed to extract their mitochondria. These autologous 
mitochondria are injected along with one sperm cell into the patient’s own oocytes in order to 
supply additional energy that might improve pregnancy rate after in vitro fertilization, IVF 
(Woods et al., 2015a) (Fig.7).  
 
In 2015, the first report has been published that documented the outcomes of AUGMENTSM 
treatment in patients at two clinics (Fakih, 2015). The study enrolled two cohorts of difficult-
to-treat women in Dubai, UAE, and Toronto, Canada, respectively. In summary, the authors 
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showed an improved pregnancy rate when the AUGMENTSM treatment was used as compared 
to conventional intracytoplasmic sperm injection, ICSI, explained by a better embryo 
morphology after fertilization of the “boosted” oocytes. However, this study has several 
shortcomings. For example, the doctors were neither blinded nor was oocyte allocation to 
experimental groups randomized. In addition, the authors have stock ownership in 
OvaScienceSM. A second study investigated the effect of AUGMENTSM treatment in women 
in Turkey with at least two previously unsuccessful IVF cycles and found a significant 
improvement in fertilization rates as compared to the previously unsuccessful IVF cycles 
(Oktay et al., 2015). Unfortunately, no controls were included here, and conclusions have to be 
taken cautiously. In 2018, Labarta and colleagues investigated the AUGMENTSM treatment in 
a randomized, controlled, triple-blinded, experimental study at the Valencian Institute of 
Infertility, Spain (Labarta et al., 2019). Up to date, this represents the most thorough clinical 
study of AUGMENTSM treatment in humans. Here, the authors received DDX4 Ab-positive 
cells from OvaScienceSM to perform AUGMENTSM treatment in women with at least one 
previously unsuccessful IVF cycle. As a control, conventional ICSI was performed on half of 
the woman’s oocytes retrieved after ovarian stimulation. In summary, the authors could not 
find any statistical difference in terms of fertilization rate, blastocyst formation rate and 
cumulative live birth rates when compared to the control group.  
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Fig.7. AUGMENTSM treatment as infertility therapy. In women having difficulties to conceive due 
to a decreased oocyte quality, ovarian cortex biopsy is taken via laparoscopy. After isolation of OSCs, 
mitochondria are extracted. After oocyte retrieval, the woman’s own oocyte is injected with the 
extracted mitochondria along with the sperm cell using ICSI. After in vitro maturation, the embryo is 
transferred back into the woman. Graphics was created using ©BioRender. 
 
Altogether, a congruent study proving the existence of OSCs in human adult ovary that have 
the potential to develop into competent oocytes is still missing. Although considering putative 
OSCs for a therapeutic approach is tempting, for example in patients facing premature ovarian 
insufficiency, further research is clearly needed to evaluate the physiological role and clinical 
relevance of DDX4 Ab-positive ovarian cells that are not yet widely accepted in the scientific 
community (Vanni et al., 2017).  
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2 AIMS 
 
The aims of this thesis are to determine the effect of chemotherapy on the human ovary, to 
investigate the cell type composition of the adult human ovarian cortex on a single-cell level 
and to characterize putative OSCs. 
 
The specific aims of the two projects were: 
 
Study I:  to assess the impact of first-line chemotherapy on the human ovarian cortex from 
pediatric and young adult cancer patients using tissue samples from fertility preservation 
programs.  
 
Study II:  to map the different cell types within the adult human ovarian cortex with special 
focus on previously reported OSCs using advanced single-cell technologies as well as to 
investigate a possible existence of germline-like stem cells based on transcriptome profile. 
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3 MATERIAL AND METHODS 
 
This section summarizes the key methods used during my PhD studies. All material and 
methods used in my studies are described in detail in the respective studies. 
 
3.1 ETHICS AND OVARIAN TISSUE DONORS 
In study I, ovarian tissue stored from a total of 43 pediatric and young adult patients for fertility 
preservation purposes was donated after informed written consent. Cryopreservation of ovarian 
tissue of pediatric patients was part of a research project approved by the Ethics Committee of 
Helsinki University Central Hospital (license number 340/13/03/03/2015) and was performed 
at Helsinki University Central Hospital (Finland). Informed written consent was given by the 
guardians of pediatric patients and patients themselves if age appropriate. Adult patients 
underwent ovarian tissue cryopreservation as part of a fertility preservation program at 
Tampere (Finland) and Oslo (Norway) University Hospitals and gave informed written consent 
for the quality control of ovarian tissue, including morphological analysis and in vitro culture. 
In accordance with the Medical Research Act (488/1999) and the Act on the Medical Use of 
Human Organs, Tissues and Cells (101/2001), no further ethical permits were needed. 
 
In study II, ovarian tissue usage for research was approved by Stockholm Region Ethical 
Review Board (Dnr. 2010/549–31/2, Dnr. 2015/798–31/2) and included a total of 21 patients. 
Small biopsies (5x5x1 mm) were taken from cesarean section (C-sec) patients’ ovarian cortex 
as well as whole ovaries from gender reassignment patients (GRPs) after informed written 
consent. All samples were collected at Karolinska University Hospital (Sweden). 
 
3.2 OVARIAN TISSUE 
3.2.1 Cryopreservation and thawing of adult ovarian cortex 
In study I, previously cryopreserved, thawed and fixed samples were used. 
 
In study II, tissues were collected, cryopreserved and thawed by our laboratory. GRP ovaries 
were trimmed using scalpels, the medulla part was removed and the remaining cortex of a 
thickness of approximately 1 mm was cut into pieces. C-sec biopsies did not require trimming 
and were cut into pieces immediately.  
 
In order to store ovarian tissue whilst ensuring the maintenance of the biological structure and 
function long-term, ovarian tissue is frozen in a controlled manner using cryo-protectants. 
In our laboratory, we are using Ethylene Glycol to protect tissue cells from freezing damage. 
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For vitrification, tissue was cut into small pieces of approximately 1x1x1 mm and placed into 
vitrification solution containing 40% Ethylene Glycol, Sucrose and 10 mg/mL human serum 
albumin (HSA). After two incubation steps of 2 min and 3 min, respectively, the tissue was 
placed into cryotubes and stored in liquid nitrogen. For thawing, cryotubes were warmed at 37 
°C before tissue pieces were transferred to thawing solutions of increasing HSA and decreasing 
sucrose concentration for 2 min, 3 min and 5 min, respectively. 
 
For slow-freezing, tissue was cut into pieces of approximately 10x10x1 mm. After a pre-
equilibration step in slow-freezing medium containing 7.5% Ethylene Glycol, Sucrose and 10 
mg/mL HSA for 30 min, max. two pieces were placed into one cryotube containing 1 mL of 
slow-freezing medium. Cryotubes were transferred into the controlled rate freezer programmed 
as follows: - 2 °C/min to – 9 °C, hold at – 9 °C for 5 min, manual seeding by briefly touching 
the outer wall of the cryotube with liquid nitrogen-soaked cotton pad, - 0.3 °C/min to – 40 °C, 
- 10 °C/min to – 140 °C. After completion, cryotubes were stored in liquid nitrogen. For 
thawing, cryotubes were warmed at 37 °C before pieces were transferred to three different 
thawing solutions containing 10 mg/mL HSA and decreasing concentrations of sucrose for 10 
min, respectively. 
 
3.2.2 Histological analysis 
In study I, tissue was freshly fixed in paraformaldehyde (PFA) or frozen/thawed and fixed in 
Bouin’s solution. In study II, tissue was freshly fixed in methanol-free formaldehyde. Fixed 
tissue was embedded in paraffin and cut into sections of 4 μm. For all subsequent staining 
methods on fixed tissue sections including immunohistochemistry and FISH, assays were 
performed on tissue sections de-paraffinized in Xylene and rehydrated through ethanol series. 
Sections were re-hydrated with dH2O and washed with Tris-buffered saline (TBS, pH 7.6).  
 
For morphological classification of ovarian follicles in study I, Bouin’s fixed ovarian cortex 
sections were stained with hematoxylin and eosin and scanned using a spectral scanner. After 
evaluation of inter-observer concordance of more than 90%, two observers counted half of the 
patient material. For this, every firth section was analyzed to avoid double counting of follicles. 
Only follicles with a visible oocyte nucleus were taken into consideration when categorized 
and measured in Pannoramic Viewer software. For categorization, a follicle was counted as 
“healthy” if the round follicle shape was preserved, no eosinophilic cytoplasm present, the 
granulosa cell layer(s) were in full contact with the oocyte and the oocyte nucleus was round, 
central and not pyknotic. If one of the above criteria did not apply, such as delocalized 
granulosa cells or a distorted oocyte nucleus shape, the follicle was counted as “atretic”. For 
classification of follicles based on developmental stage, established morphological criteria 
were followed (Gougeon, 1996): oocytes of primordial follicles were surrounded by one layer 
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of flattened granulosa cells; intermediary follicles showed flattened and at least two cuboidal 
granulosa cells; follicles were classified as primary follicles if one full layer of cuboidal 
granulosa cells was seen; secondary follicles had more than one full layer of cuboidal granulosa 
cells (see also Fig.1C-G). 
 
To determine the amount of fibrotic areas in ovarian tissue in study I, trichrome stain kit was 
performed on Bouin’s fixed ovarian cortex sections. Firstly, to stain cell nuclei in black, tissue 
sections were incubated in Weigert’s hematoxylin for 5 min. An incubation in Biebrich 
scarlet/acid fuchsin solution for 15 min stained cytoplasm and muscle fibers in red. Following 
an incubation in phosphomolybdic/phosphotungstic acid solution for 10 min, tissue collagen 
was detected by staining in aniline blue solution (5 min) and acetic acid solution (3 min). After 
dehydration in solutions with an increasing ethanol concentration, tissue was cleared, mounted 
and imaged using light microscopy and analyzed using ImageJ. 
 
To detect stromal cell death in ovarian tissue in study I, TUNEL (terminal deoxynucleotidyl 
transferase dUTP nick end labeling) staining assay was performed on PFA-fixed ovarian cortex 
sections. The sections were incubated with Proteinase K to remove protein followed by an 
incubation in TUNEL reaction mixture for 1 h at 37 °C. This mixture contains the enzyme 
terminal deoxynucleotide transferase (TdT). TdT catalyzes the attachment of fluorescently 
labeled deoxynucleotides to the 3’hydroxyl termini of DNA and thereby, enables the 
visualization of DNA double-strand breaks. As positive control, tissue sections were treated 
with DNase I prior to TUNEL reaction. As negative control, sections were incubated in reaction 
mixture without TdT enzyme. Images were analyzed using confocal microscopy and ImageJ. 
 
3.2.3 Immunohistochemistry 
For detection of protein expression in tissue in study I and II, immunohistochemistry on PFA-
fixed ovarian cortex sections was performed. Antigen retrieval was done in sodium citrate 
buffer (pH 6) at 96 °C and unspecific binding was blocked using serum. Primary antibodies 
were incubated over night at 4 °C. After thorough tissue washing, fluorescently labeled 
secondary antibodies and DAPI as nuclear counterstain were applied for 1h (study I) or 30 min 
(study II) on room temperature. Tissue sections were washed, mounted and analyzed using 
confocal microscopy and ImageJ. 
 
3.2.4 Fluorescence in situ Hybridization 
RNA transcript can be detected and localized in tissue sections using RNA-fluorescence in situ 
hybridization (FISH) and was carried out in study II. For localization of DDX4 transcript, 
RNAscope® technology was performed on PFA-fixed ovarian cortex from GRPs. Using the 
RNAscope® Multiplex Fluorescent Detection kit, signal of DDX4 transcript was detected and 
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further amplified by the help of TSA amplification. As positive control, probes targeting 
Ubiquitin C were included and as negative control, the absence of probe signal from bacterial 
gene DabB was confirmed. Nuclei were visualized with Hoechst and images were analyzed 
using confocal microscopy and ImageJ.  
 
3.2.5 Steroid analysis 
For the quantification of steroids produced in ovarian tissue cultures in study I, ultra-
performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) was 
performed as described earlier (Hao et al., 2018) using culture media samples from tissue 
previously cultured for seven days (Asadi Azarbaijani et al., 2015) and stored on - 80 °C. Media 
samples of day 4 and day 7 were quantified for the following steroids: cortisol, corticosterone, 
estradiol, androstenedione, 17a-hydroxyprogesterone, progesterone, dehydroepiandrosterone, 
dihydrotestosterone, and testosterone. As negative controls, blank media samples were 
included. 
 
3.3 OVARIAN CORTEX SINGLE CELLS 
3.3.1 Tissue dissociation into single cells 
Prior to all single-cell experiments in study II, frozen/thawed ovarian cortex was dissociated 
into single-cell suspensions. This method was established using bovine ovarian cortex which 
allowed for extensive testing of various digestion enzymes, enzyme mixtures and incubation 
times.  
 
For dissociation of adult human ovarian cortex into single cells, tissue was minced into small 
pieces using scalpels and enzymatically digested using 1 mg/mL Collagenase I A, 50 μg/mL 
LiberaseTM and 100 U DNase I in a shaking water bath for a maximum of 50 min at 37 °C. 
After blocking of enzymes using 10% FBS, cells were pelleted, resuspended and filtered 
through a 40 μm cell strainer. Cell number was determined using Moxi automated cell counter 
with a size setting of 7.5 – 26 μm. Cell viability was subsequently analyzed using flow 
cytometry and DAPI to discriminate dead cells. 
 
3.3.2 Fluorescence-activated cell sorting and flow cytometry 
Fluorescence-activated cell sorting (FACS) and flow cytometry (FC) were performed for 
determination of cell viability, surface protein detection in single-cell suspensions and/or 
isolation of putative OSCs from frozen/thawed ovarian cortex in study II.  
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For FACS of putative OSCs, the previously published protocol was followed (Woods et al., 
2013). Briefly, the single-cell suspension was serum blocked, followed by staining with DDX4 
Ab (ab13840, Abcam) and subsequently with fluorescently labeled secondary Ab. All 
incubation steps were carried out for 20 min at 4 °C. The optimal DDX4 Ab concentration of 
10 μg/mL was determined by titration experiments prior to and used for all subsequent DDX4 
Ab staining. DAPI labeling was used for dead cell discrimination. Prior to FACS and FC, 
samples were filtered through FACS tube mesh of a size of 35 μm. DDX4 Ab-positive and Ab-
negative cells were sorted based on fluorescence intensity using FACSAria Fusion. 
 
For FC, the same staining protocol was followed with various different Abs targeting surface 
proteins. In the case of surface marker screening, the BD LyoplateTM provided a panel of 242 
surface markers and respective isotype controls in a 96-well plate format containing one marker 
per well. Where appropriate, a co-stain for DDX4 Ab was carried out. Surface marker 
expression was analyzed using CytoFlex S flow cytometer. 
 
As negative controls in all flow experiments, secondary Ab only, fluorescence minus one 
(where appropriate) and isotype samples were included and used for analysis and/or sorting of 
populations of interest. 
 
3.3.3 Immunocytochemistry 
Protein expression in ovarian cortex single cells was analyzed by immunocytochemistry in 
study II. For this, cells were attached to glass slides using Cytospin before being fixed in PFA 
for 10 min on room temperature. Once the samples have dried fully, cells were permeabilized 
with Triton X and serum blocked. Primary Abs diluted in blocking solution were applied to 
glass slides at 4 °C over night. After thorough washing, slides were incubated with 
fluorescently labeled secondary Abs diluted in blocking solution. Hoechst was used as nuclear 
counterstain. After mounting, cells were imaged using confocal microscopy and analyzed in 
ImageJ. 
 
3.3.4 Single-cell mRNA sequencing 
Single-cell mRNA sequencing (scRNA-seq) provides information on the gene expression 
profiles of single cells at a given time point and was part of study II. Here, the 10x chromium 
platform was used which enables sequencing of a large number of cells to relatively low costs 
when compared to other scRNA-seq methods. ScRNA-seq was performed on ovarian cortex 
from one unsorted GRP, three pooled unsorted C-sec patients as well as sorted DDX4 Ab-
positive and Ab-negative cells from the ovarian cortex of three pooled GRPs. Viable cells were 
either enriched using the Dead cell removal kit (for unsorted cell samples) and magnetic beads 
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or using DAPI in FACS to discriminate dead cells (for sorted cell samples). Sorted and unsorted 
cell samples were prepared for GEM formation on the same day, respectively. 
Prior to loading of cells into the chromium controller, an aliquot of single-cell suspensions was 
stained with Trypan Blue, cells were counted in a Bürker Chamber and viability ratio was 
determined to be taken into account for GEM formation. All libraries were sequenced on a 
NovaSeq 6000 using a S1 flow cell and one lane per sample. Sequencing reads were aligned to 
the human genome hg19 using STAR aligner (Dobin et al., 2013). After initial filtering using 
Cell Ranger, around 6,000 cells per sample were kept with a sequencing depth of around 70,000 
reads per cell and further analyzed using Seurat in R for downstream analysis (Butler et al., 
2018; Stuart et al., 2019). Only genes detected in at least three cells were considered. 
Briefly, further data filtration was performed to remove potential doublets and cells of low 
quality by excluding cells with a mitochondrial gene expression of more than 25% and less 
than 200 or more than 7000 genes expressed. In total, around 24,000 cells were kept for gene 
expression and cluster analysis. 
 
3.4 STATISTICS 
In study I, statistical analysis was performed using SigmaStat package SPSS and R. Mann-
Whitney U test was used for comparison of exposed and unexposed patients in the following 
experiments: follicle densities, follicle and oocyte nucleus diameters, steroid concentrations, 
fibrotic tissue areas, TUNEL signal and γH2AX foci numbers between the two groups. To 
compare the proportions of different classes between the groups, Chi-square test was used. 
Spearman’s rank correlation was used to determine correlations between morphological 
measures and the following variables: age, cyclophosphamide equivalent does (CED), isotoxic 
dose equivalent (DIE) and steroid concentrations. In cases that more than one variable 
correlated with morphological measures, the major predictor was determined using forward 
stepwise regression analysis. Results are shown as median with interquartile range and 
considered statistically significant at p-values < 0.05. 
 
For scRNA-seq analysis in study II, statistical analysis was performed using R. Marker genes 
discriminating the different clusters were selected among highly expressed genes (p-value < 
0.01 and log(fold-change) > 0.25) using Wilcoxon RankSum test.  
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4 RESULTS AND DISCUSSION 
4.1 IMPACT OF CHEMOTHERAPY ON HUMAN OVARIAN FOLLICLES AND 
STROMA 
Cancer patients undergoing chemotherapy and/or radiotherapy are at risk of premature ovarian 
insufficiency. Ovarian tissue cryopreservation is an established fertility preservation method 
and offered to adult patients falling into the high-risk group of potential fertility loss, with the 
possibility of OTT upon the patient’s recovery and desire for a child. In the case of pediatric 
patients, indication for fertility preservation is given when assigned to anti-cancer treatment 
considered of very-high risk. Usually, first-line chemotherapy is regarded as low risk and as 
such, patients are not referred to undergo ovarian tissue cryopreservation. However, patients 
treated with a regimen that classified as low/medium risk at first might fall into the high-risk 
group when assigned to second-line chemotherapy treatments. In these cases, the patients have 
been exposed to (multiple rounds of) chemotherapy prior to ovarian tissue cryopreservation. A 
limited number of studies investigated the impact of chemotherapy treatment on ovarian 
follicles prior to ovarian tissue cryopreservation in pediatric and young adult patients (Abir et 
al., 2016; Asadi Azarbaijani et al., 2015; Duncan et al., 2015; El Issaoui et al., 2016; Fabbri et 
al., 2012; Familiari et al., 1993; Marcello et al., 1990; McLaughlin et al., 2017).  
In study I, the impact of first-line chemotherapy on quantity and quality of ovarian follicles as 
well as the quality of ovarian stroma was evaluated. For this, we investigated a patient cohort 
(age 1 – 24 years) exposed to first-line chemotherapy prior to ovarian tissue cryopreservation 
(treated) compared to patients that have not been exposed to chemotherapy treatment at the 
time of tissue cryopreservation (untreated) using various methods (Fig.8). Of note, following 
the guidelines of the Nordic Society of Pediatric Hematology and Oncology (NOPHO 2013), 
none of the treated patients in our cohort fell into the very high-risk group and hence, no 
indication for ovarian tissue cryopreservation would have been given. This issue, among others, 
was also addressed by Shapira et al. (Shapira et al., 2020) and clarified in our response letter 
(Pampanini et al., 2020). 
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Fig.8. Study I design and main results. Frozen/thawed ovarian cortex from treated and untreated 
patients referred to ovarian tissue cryopreservation in Norway and Finland was either Paraffin-
embedded and sectioned or cultured in vitro. To determine the impact of chemotherapy on ovarian 
follicles and stroma, sections were used for morphological analysis of ovarian follicles. Furthermore, 
immunostaining was performed to evaluate the extent of follicle activation, DNA damage and fibrotic 
lesions in ovarian tissue. To investigate steroid production in ovarian tissue, pieces of cortex were 
cultured. Culture medium of day 4 and 7 was analyzed in terms of steroid levels using mass spectrometry 
(UPLC MS/MS). In treated patients, follicles were found to be more atretic and smaller in size but 
neither follicle activation nor DNA damage was increased in follicles. Ovarian stroma of treated patients 
showed enlarged areas of fibrosis and DNA damage and steroid production was reduced compared to 
untreated patients. Graphics was created using ©BioRender. 
 
4.1.1 Characterization of follicles 
Morphometric analysis of ovarian tissue sections was performed to classify follicles based on 
health and developmental stage. While the total follicle density did not differ between treated 
and untreated patients, the density of atretic primordial and intermediary follicles was 
significantly increased and the density of intact primary follicles was significantly decreased 
in the treated patient group. The diameter of primordial follicles and their oocyte nuclei as well 
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as of intermediary follicles was significantly reduced compared to the untreated patients’ 
follicles. Correlation analysis revealed a positive correlation of atretic (total, primordial and 
intermediary) follicles with CED and DIE, while age correlated positively with the density of 
atretic primordial follicles only. The density of intact primary follicles negatively correlated 
with CED and DIE. Furthermore, the size of follicle and oocyte nucleus negatively correlated 
with DIE. 
 
In order to investigate whether primordial follicles of treated patients show an increased 
activation as suggested by Prof. Meirow’s group’s “burnout hypothesis”, the ratio of intact 
growing follicles (intermediary and primary follicles) and total follicles (primordial, 
intermediary and primary follicles) was determined (Kalich-Philosoph et al., 2013). A 
significantly lower ratio of intact growing/total follicles was found in the treated patient group 
which is not in line with the expected scenario in the case of follicle activation. This reduction 
can be explained by an overall decrease of intact primary follicles observed in treated patients. 
To confirm this, FOXO3A as a marker of follicle activation was evaluated using 
immunohistochemistry: upon activation of follicles via PI3K/AKT signaling pathway, 
FOXO3A as downstream target translocates from the nucleus to the cytoplasm. Consistent with 
the previous finding, we found FOXO3A expressed in the nucleus in both groups, again 
indicating no chemotherapy-induced activation of follicles. 
 
Furthermore, ovarian follicles of treated patients did not display an increased DNA damage. 
DSBs were studied by staining of phosphorylated H2AX (γH2AX) expression in oocyte nuclei 
using immunohistochemistry. No difference in the amount of γH2AX signal was found 
between treated and untreated patients. 
 
4.1.2 Steroid production by ovarian tissue  
Ovaries are regulated by and produce steroids in vivo. To investigate the functionality of 
ovarian tissue from treated and untreated patients, steroid concentration was determined in 
culture media of ovarian tissue cultured for seven days (Asadi Azarbaijani et al., 2015) using 
UPLC-MS/MS. The concentration of measured steroids increased in both patient groups over 
time (day 4 versus day 7), a sign of active steroid production in culture. However, significantly 
lower levels of estradiol, androstenedione, testosterone and progesterone were detected in 
treated compared to untreated patients. Further analysis revealed a positive correlation of 
steroid levels and density of intact primordial and intermediary follicles. 
 
4.1.3 Analysis of ovarian stroma 
To evaluate the health of somatic ovarian tissue cells surrounding the follicles, ovarian stroma 
from uncultured tissue was further evaluated in terms of DNA damage and prevalence of 
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fibrosis. Fragmented DNA in somatic cells was detected using TUNEL staining and revealed 
a larger area of TUNEL positive signal in the treated patient group to various degrees. Two of 
seven analyzed treated patients displayed rather low TUNEL signal that was comparable to 
levels of untreated patients, while the remaining five showed a significantly greater positive 
area when compared to untreated patients. Similarly, fibrosis as visualized by trichrome stain 
assay to detect newly formed, collagen-rich areas revealed significantly greater intensity and 
an enlarged area in the group of treated patients as compared to untreated ones. 
 
4.1.4 Discussion 
Qualitative and quantitative analysis of follicles and stroma cells in ovarian tissue revealed a 
negative impact of first-line chemotherapy exposure on ovarian tissue prior to cryopreservation 
for fertility preservation.  
 
As it is inherent to retrospective cohort studies, a balanced design of samples is difficult, 
especially with this sensitive patient group and its precious study material. In this study, patient 
diagnoses were highly variable and so were the treatment regimens within the treated patient 
group. There was a significant difference in age between the two groups with the treated group 
being significantly younger compared to the untreated group. Furthermore, the time to tissue 
cryopreservation upon chemotherapy treatment varied between 7 – 55 days. Despite various 
degrees of chemotherapy exposure as reflected in variable CED and DIE values, none of the 
patients treated with first-line chemotherapy fell into the very-high risk group and would not 
have been offered ovarian cryopreservation following the current guidelines (NOPHO 2013). 
However, any drug-specific effect could not be studied here. 
 
Morphometric analyses showed an increased density of atretic primordial and intermediary 
follicles upon chemotherapy exposure. In addition, intact primordial and intermediary follicles 
and the respective oocyte nuclei of primordial follicles were smaller in size in the treated patient 
group compared to untreated patients in our study and compared to follicle and oocyte nucleus 
sizes of the same age group in Westergaard et al. (Westergaard et al., 2007). Along with the 
observed decreased density of intact primary follicles in treated patients, a smaller size might 
reflect an impaired developmental potential of early follicles that survive chemotherapy 
treatment. This supports earlier findings of a lower in vitro developmental capacity of follicles 
from cultured ovarian tissue exposed to first-line chemotherapy before tissue cryopreservation 
(Asadi Azarbaijani et al., 2015). 
 
To further investigate potential underlying mechanisms of the observed increased follicle 
atresia and decreased developmental potential, premature ovarian follicle activation and follicle 
apoptosis were evaluated.  
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Firstly, when analyzing the hypothesis of chemotherapy-induced follicular burnout (Kalich-
Philosoph et al., 2013) in our study material, we did not detect an increased follicle activation 
based on morphological analysis (intact growing versus total follicles). Nor on molecular basis, 
as FOXO3A expression was restricted to the oocyte nucleus of primordial follicles indicating 
a quiescent follicle state. It should be considered that FOXO3A is only one of the targets of 
PI3K/AKT signaling and ideally, more players of this pathway should be investigated to draw 
firm conclusions, such as AKT, TSC1 and TSC2. Additionally, ovary cryopreservation was 
carried out within a few weeks after last chemotherapy exposure (in the case of FOXO3A 
stained tissue samples, patients had undergone ovary cryopreservation after 14 – 35 days) 
which could have led to us missing the time point of follicle activation, as suggested by Shapira 
et al. (Shapira et al., 2020). Re-localization of FOXO3A to the nucleus over time cannot be 
excluded from our study. Indeed, it was shown in a mouse study that nuclear localization of 
FOXO3A can be restored when oocytes are cultured under in vitro conditions that maintain 
dormancy (Nagamatsu et al., 2019). In humans, there is no evidence in literature yet to support 
a potential return back into dormancy once the follicle has been activated.  
 
Secondly, DNA damage as an inducer of follicle atresia was investigated by 
immunohistochemistry of γH2AX. No difference in numbers of foci positive for γH2AX in 
intact primordial follicles of treated and untreated patients was found. Importantly, H2AX 
phosphorylation upon DNA damage was reported to take place within hours in rodents 
(Gonfloni et al., 2009; Petrillo et al., 2011; Rossi et al., 2017). Here again, considering the 
tissue sampling time (in the case of γH2AX stained tissue samples, patients had undergone 
cryopreservation after 8 – 55 days after chemotherapy exposure), it is likely that we missed 
differences in γH2AX signal. If we assume that the kinetics of DNA damage repair are 
conserved between mouse, bovine and human ovarian follicles, follicles had the chance to 
either resolve DSBs by repair mechanisms or undergo atresia during this time. PI3K/AKT 
signaling is considered a major pathway in maintenance of dormancy or trigger of primordial 
follicle activation. This pathway was reported to be disrupted in mice upon in vivo treatment 
with cyclophosphamide, mediating premature follicle loss through massive activation and 
burnout of the ovarian reserve within one week (Kalich-Philosoph et al., 2013). A recent study 
on bovine primordial follicles has revealed that PI3K/AKT pathway activation via PTEN 
inhibition hampers DNA repair mechanisms in dormant follicles. Ultimately, this led to 
unresolved DNA damage and potentially follicle death. These effects were found after 24 hours 
of tissue exposure in vitro (Maidarti et al., 2019). This would suggest that we did not find any 
differences in DNA damage of primordial follicles between treated and untreated patients 
because damaged follicles have already undergone atresia at the time of analysis and were 
classified as atretic follicles. 
 
It must be acknowledged that we are looking at snapshots of the ovary condition at the time 
point of tissue fixation and thus ovary dynamics are being missed. The valid concern of an 
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overestimate of atretic follicle numbers due to tissue fixation is being debated continuously in 
literature. This concern should be kept in mind in fields that heavily rely on histological 
analysis, such as ovary research. In an ideal research situation, to fully understand how 
increased follicle atresia is mediated upon chemotherapy exposure in human, one should study 
ovarian tissue exposed to chemotherapy within one week at several time points and include 
various molecular key players of follicle activation (AKT, TSC1 and TSC2, FOXO3A, RPS6), 
DNA damage and apoptosis (γH2AX, CASP3, BCL2, PUMA) as well as DNA repair 
(MRE11, ATM, RAD51). Obviously, ethical concerns interfere with this hypothetical study 
design. 
 
It is widely accepted that theca and granulosa cells up until secondary follicle stage are 
responsible for steroid production in the ovary. However, we still detected steroids in tissue 
culture medium when morphological analysis of ovarian tissue revealed very few secondary 
follicles and no antral follicles. Hence, steroid levels detected in the media of cultured ovarian 
tissue were rather produced by pre-antral follicles (intermediary and primary) or ovarian stroma 
cells. Lower steroid levels detected could be an indication for the reduced developmental 
potential of growing follicles or for a damaged stroma. With respect to the first hypothesis, we 
do see a reduced developmental potential of ovarian follicles in treated patients, as outlined 
above. With respect to the latter, we indeed detected a higher prevalence of fibrosis and 
increased DNA damage in the ovarian stroma of treated patients. Fibrosis is the process of 
excess deposition of extracellular matrix components, such as collagen, in tissue, often upon 
repeated injury, chronic inflammation or radiation, and is known to impair tissue cell function 
(Wynn, 2008). Furthermore, increased stiffness of ovarian tissue, e.g. induced by fibrosis, 
could explain the impaired developmental potential of early follicles in treated patients. Upon 
activation, follicles migrate from the rigid microenvironment within the cortex towards the 
inner, softer region of the ovary, the medulla (Hsueh et al., 2015). More studies are needed to 
investigate whether an increase in fibrotic areas is also detected in the medulla of treated 
patients’ ovaries as compared to untreated ones, like that seen in the cortex. It was shown 
recently, that collagen deposition in human ovarian cortex continuously increases and more 
strikingly, elastic fibre content decreases with age (Ouni et al., 2020), potentially contributing 
to the onset of menopause. Additionally, the extracellular matrix and its ability to compress 
surrounding structures was shown to provide environmental cues for maintenance of dormancy 
of mouse follicles in vitro (Nagamatsu et al., 2019). An increased collagen deposition due to 
fibrotic lesions could hence contribute to the development of premature ovarian insufficiency 
in chemotherapy-treated patients. 
 
A fibrosis-induced impaired cell function along with greater numbers of apoptotic somatic cells 
found in this study might explain the observed reduced steroid production in ovaries of treated 
patients. This is in line with another study that showed reduced estrogen levels in culture 
medium of human ovarian tissue treated with chemotherapy agents as compared to untreated 
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ones (Oktem et al., 2007b). One should consider that any steroid levels measured in ours and 
other studies might only reflect the in vitro situation upon tissue culture. Presence of fibrosis 
and stromal apoptosis, however, was analyzed in uncultured tissue and is more likely to reflect 
the in vivo situation. 
 
In summary, exposure to first-line chemotherapy prior to ovarian tissue cryopreservation 
significantly alters the quality of the tissue. These alterations are reflected in an impaired 
follicle morphology, steroid production and stroma quality. It is currently unclear whether this 
type of damage might be reparable in vivo upon OTT as at least in adults, no difference in terms 
of ovarian function recovery was observed between OTT with chemotherapy-exposed or -
unexposed tissue (Poirot et al., 2019). 
 
4.2 CHARACTERIZATION OF THE HUMAN OVARIAN CORTEX 
In multiple centers worldwide, human ovarian cortex is cryopreserved for fertility preservation 
purposes, but its cell type composition had not been studied yet at the single-cell level. Several 
groups reported the existence of OSCs in the adult human ovarian cortex that have the potential 
to differentiate into oocytes (Clarkson et al., 2018; Ding et al., 2016b; Silvestris et al., 2018; 
White et al., 2012). These putative OSCs have been used for treatment of women struggling to 
conceive in specific clinics and could potentially provide revolutionary treatment options for 
cancer survivors, too.  
 
In study II, we analyzed the ovarian cortex cells in general and the putative OSCs in particular 
by means of gene and protein expression analysis at the single-cell level (Fig.9).  
 
4.2.1 Deconvolution of different cell populations 
Using scRNA-seq, we found that the adult human ovarian cortex consists of six main cell types, 
namely oocytes, immune cells (including monocytes and T-cells), granulosa cells, endothelial 
cells, perivascular cells and stroma cells. Cortex cells from C-sec biopsies and GRP ovaries 
showed the same composition and a similar abundance of the identified cell types. Upon 
integration of scRNA-seq data from adult human ovarian medulla (Fan et al., 2019), we saw 
all cortical cell types also being present in the medulla, except for oocytes that were unique to 
the cortex data set. Additional cell types within the endothelial cell cluster, such as lymphatic 
cells, the immune cell cluster, e.g. B-cells, and theca cells observed in the medulla (Fan et al., 
2019) were not found in the cortex. Furthermore, cortex granulosa cells did not cluster together 
with the different granulosa cell clusters in the medulla. 
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Fig.9. Study II design and main results. Ovarian cortex from GRPs and C-sec patients was digested 
into single cells using enzymes. Single ovarian cortex cells were either used unsorted for scRNA-seq 
analysis and surface marker screening or sorted into DDX4 Ab-positive and Ab-negative populations 
by FACS. DDX4 Ab-positive/negative populations were either scRNA-sequenced directly or cultured 
in vitro before subjected to scRNA-seq. Downstream analysis of scRNA-seq data revealed cell type 
information and integration of data sets (Fan et al., 2019; Li et al., 2017) was performed for further 
validation. Six main cell types could be distinguished among ovarian cortex cells. DDX4 Ab-positive 
cells were found to display characteristics of perivascular cells at the transcriptional and protein level. 
No cell with a gene expression profile similar to germline-like stem cells was found. Graphics was 
created using ©BioRender. 
 
4.2.2 Characterization of DDX4 Ab-positive cells 
We followed the previously reported protocol to isolate putative OSCs using FACS targeting 
DDX4 (Woods et al., 2013) and detected a small fraction of ovarian tissue cells (5 – 11.5%) to 
be positive for DDX4 Ab signal. Based on transcriptome profiling using scRNA-seq analysis, 
DDX4 Ab-positive cells revealed a perivascular cell nature with typical perivascular markers 
being highly expressed, such as MCAM, TAGLN and CD9, while DDX4 was absent in these 
cells at the transcriptional level. At the protein level, DDX4 Ab-positive cells showed high 
expression of seven surface proteins as compared to the DDX4 Ab-negative fraction, including 
MCAM, CD44 and CD9, which could be mapped back to the perivascular cell cluster in 
scRNA-seq data. DDX4 Ab-positive and Ab-negative cells cultured under OSC conditions 
(Zhang et al., 2015) showed distinct gene expression profiles which overlapped with 
perivascular cells and stroma cells in the established single-cell map, respectively. In situ 
localization of DDX4 mRNA by FISH further validated its expression in oocytes only, while 
perivascular cells did not express DDX4. Finally, immunohistochemistry on ovarian cortex 
sections and immunostaining of semi-digested ovarian cortex confirmed that DDX4 Ab signal 
is co-expressed with perivascular markers in cells of blood vessels. These results showed that 
DDX4 Ab used for isolation of putative OSCs in fact targets perivascular cells. 
 
4.2.3 Search for putative OSCs 
Unbiased and independently of DDX4 Ab-positivity, we sought to determine whether there are 
any cells residing in the adult human ovary that display a gene expression profile similar to 
putative OSCs or FGCs. ScRNA-seq technology is a powerful tool to detect small sub-
populations and provides an unprecedented opportunity to dissect gene expression profiles of 
heterogeneous samples at single-cell resolution. While bulk mRNA sequencing easily 
overrides the gene expression profile from rare cells, scRNA-seq is sensitive for their detection.  
However, we acknowledged the fact that we could potentially miss out on cells showing an 
OSC- or FGC-like gene expression profile in our data set due to the expected low numbers of 
those cells (White et al., 2012). Hence, we integrated scRNA-seq data of female fetuses from 
a previously published fetal human data set (Li et al., 2017), thereby introducing – or increasing 
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the numbers of – cells with an FGC gene expression profile. Oocytes, granulosa cells and 
endothelial cells from the adult data set clustered with oogonia, late granulosa cells and 
endothelial cells from the fetal data set, respectively. However, no adult cells resembled female 
FGCs from the fetal data set in their gene expression profile. This integration analysis led us to 
conclude that there are no germline-like stem cells within the adult human ovarian cortex. 
 
4.2.4 Discussion 
Our single-cell map of adult human ovarian cortex cells in study II suggests that there are six 
main cell types. All of these cell types; oocytes, immune cells, granulosa cells, endothelial cells, 
perivascular cells and stroma cells; have been previously reported separately in various studies. 
These six cell types could be clearly distinguished from each other based on their 
transcriptional profile and were also mostly found in the inner, medullary region of the adult 
human ovary (Fan et al., 2019). However, previous reports on the existence of putative OSCs 
could not be confirmed here. Whether with the help of DDX4 Ab used for OSC enrichment 
(Woods et al., 2013) or following an unbiased bioinformatics approach by integrating female 
FGC transcriptome data (Li et al., 2017), none of the ovarian cortex cells showed a gene 
expression profile consistent with the transcriptome of OSCs or FGCs.  
 
The single-cell map of ovarian cortex cells established in this study can serve as a reference for 
future research to study i.e. effects of aging, disease, chemical exposures, and treatments. 
Ideally, ovarian tissue from healthy, untreated women of reproductive age is being used to 
generate such a reference map. However, this type of tissue is hardly accessible and rarely 
available. Hence, cortex obtained from C-sec biopsies and GRP ovaries represent good 
alternatives and are widely used in human ovary research. For example, ovarian tissue from 
GRPs has also been used when human OSCs were originally reported (White et al., 2012). An 
important aspect to consider is that both donor types are under a special endocrine environment 
at the time of sampling due to either pregnancy or androgen treatment, respectively. It was 
shown that follicles in GRP ovaries do not differ in number, distribution and quality when 
compared to untreated women (De Roo et al., 2017), and pregnancy can still be achieved upon 
discontinuation of hormone treatment (Light et al., 2014). Hence, upon androgen treatment, the 
endocrine and reproductive potential of ovaries from GRPs is not fully lost but temporarily 
suppressed. In our study, we found the same cell type composition and a similar cell type 
abundance in ovarian cortex from C-sec patients and GRPs, indicating that the driving 
transcriptome profile of each cell type was not affected by treatment. Importantly, the same 
cell types were identified in the human ovarian medulla from cancer patients that have not 
undergone any treatment prior to ovary sampling (Fan et al., 2019). However, more in-depth 
analysis is needed to investigate if the abundance of certain cell types might be affected and if 
so which signaling pathways might be altered upon the respective hormone treatment, 
especially in steroidogenic cell types such as oocytes and granulosa cells.  
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The fact that we found cortical granulosa cells clustering separately from the medulla upon 
integration of the medulla data set by Fan and colleagues probably represents the different parts 
of ovarian tissue used in the respective studies. Granulosa cells in primordial follicles (more 
likely to be found in our cortex data set) are known to express a different gene expression 
profile compared to granulosa cells in growing follicles (more likely to be found in the medulla 
data set) (Ernst et al., 2018). Indeed, the granulosa cells in the cortex clustered together with 
fetal late granulosa cells confirming their identity as primordial follicle granulosa cells. 
 
DDX4 Ab as a tool for OSC isolation has been debated for many years now and so far, no in 
silico studies can confirm that an external epitope is to be expected in the human DDX4 protein 
(Zarate-Garcia et al., 2016). However, experimental studies by us and others show that DDX4 
Ab indeed binds to a fraction of unpermeabilized ovarian tissue cells in flow analyses. When 
HEK932T cells were transfected with a construct expressing the C-terminal (potentially 
external) end of DDX4, DDX4 signal was detected in the cell nucleus, the cytoplasm and 
indeed also on the cell surface (Clarkson et al., 2019). In our study, cells isolated following the 
OSC isolation protocol (Woods et al., 2013) showed a gene and protein expression profile of 
perivascular cells. Perivascular cells include smooth muscle cells and pericytes that were 
reported to originate from the same stem cell progenitor (Kumar et al., 2017). In the 
endometrium for example, MCAM-positive pericytes have been suspected to serve as a tissue 
progenitor cell population required for endometrial regeneration (Spitzer et al., 2012). In the 
fetal mouse testis, multipotent perivascular progenitor cells were observed to give rise to 
smooth muscle cells, pericytes and Leydig cells, the male counterpart of theca cells (Kumar et 
al., 2018). Depending on their tissue of origin, perivascular cells display proliferative and 
regenerative characteristics which had been exploited in several in vitro differentiation assays 
(Avolio et al., 2017) and in regenerative therapy (Cathery et al., 2018). This could explain the 
observed proliferative capacity of DDX4 Ab-positive cells upon culture under OSC conditions 
in vitro (Ding et al., 2016b; Silvestris et al., 2018; White et al., 2012). OSC culture conditions 
vary slightly between the different studies but usually include an irradiated embryonic feeder 
layer and multiple growth factors to provoke proliferation and prevent cell differentiation, such 
as leukemia inhibitory factor (LIF), basic fibroblast growth factor (bFGF) and epidermal 
growth factor (EGF). Whether perivascular cells isolated from the adult ovarian cortex could 
potentially be differentiated into oocyte-like cells using above mentioned culture conditions 
remains to be investigated. 
 
In order to investigate the existence of OSCs in the adult human ovary independently of DDX4 
Ab, we performed pure bioinformatics analysis. For this, the previously published single-cell 
data set of human female FGCs (Li et al., 2017) was combined with our adult cortex datasets. 
Single-cell transcriptomic technologies are booming and provide powerful tools to deconvolute 
heterogeneous tissues at the single-cell level, especially when investigating small 
subpopulations. The integration of data sets across different platforms is a potent way to 
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validate and strengthen findings and is, with more and more single-cell data sets being 
available, more widely applied (Adey, 2019). However, this increased sensitivity of scRNA-
seq that provides us with such great detail on rare events comes with its limitations. One of it 
is the requirement for tissue digestion into single-cell suspension prior to scRNA-seq. Usually, 
tissue digestion is performed by a combination of mechanical and enzymatic disruption. In fact, 
this applies to all single-cell analyses, including scRNA-seq and FACS. Protein expression is 
considered more robust if certain enzymes are avoided, e.g. Trypsin which has a high 
proteolytic activity potentially leading to false negative results in flow analysis. However, it 
was reported earlier that prolonged handling times and enzyme treatment can affect the 
transcriptional profile of cells (van den Brink et al., 2017). Furthermore, different tissue 
digestion protocols might enrich for certain cell types. Optimally, the digestion protocol yields 
a viable single-cell suspension that represents all cell types present in the tissue without altering 
their gene expression profile nor their abundance relative to in vivo. In reality, this is difficult 
to assess and control for and careful optimization of handling protocols has to be ensured. 
Subsequent enrichment of cells by different sorting strategies, such as FACS, has been shown 
to be another potential stress factor to the cells and might induce altered gene expression 
profiles (van den Brink et al., 2017). Here, we established a tissue dissociation protocol that 
yielded an adequate cell number and quality fulfilling the requirements for scRNA-seq using 
the 10x platform (e.g. > 80% viable cells). In fact, the cell type composition of ovarian cortex 
was very similar to the human ovarian medulla (Fan et al., 2019) and the same as recently 
reported in a single-cell study on non-human primate ovaries (Wang et al., 2020). All three 
studies used a different approach of tissue digestion into single cells.  
 
In our study, we successfully and consistently identified expected somatic cell types as well as 
rare events, such as oocytes. However, certain cell types, such as neurons and epithelial cells 
have been previously reported to be found in the ovary but could not be detected in our data 
set. Reports about the presence of neurons in the human ovary are rare. Their presence was 
shown by immunohistochemical staining of tissue sections and were localized to the medullary 
region (Anesetti et al., 2001). In the mouse, neurons are mainly found in the medulla, too, with 
projections into the cortex (McKey et al., 2019). Intact neurons with their long cellular 
projections are difficult to isolate by standard tissue digestion protocols and are preferably 
analyzed by single-nuclei mRNA sequencing (Nguyen et al., 2018). The to date uncertain 
presence of neurons in the human cortex together with their unique cell morphology that makes 
them vulnerable to tissue digestion might explain the absence of neurons in our data set. In 
addition, epithelial cells known to cover the ovarian cortex and making up the ovarian surface 
epithelium (Auersperg et al., 2001) were missing in our data set. This one external layer of 
single cells is fragile, and we see it easily coming off when handling the ovaries. After ovary 
trimming, freezing, thawing and dissociation of the cortex, we might have lost those few 
epithelial cells expected to be found on a 10x10 mm piece of ovarian cortex. These missing 
cell types, however, do pose the question if other cell types got lost during sample preparation 
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and whether the observed absence of cells displaying a transcription profile similar to FGCs is 
real or due to technical limitations. Recently, critique was raised with regards to methodologies 
used in our sample preparation (Bhartiya et al., 2020). The authors claim that OSCs could not 
have been detected due to a low centrifugation speed. However, it needs to be highlighted here 
that Bhartiya and colleagues report stem cell populations among the mammalian ovarian 
surface epithelium that are isolated using a centrifugation speed of 1,000 g (Parte et al., 2011; 
Patel et al., 2018). These populations differ in location (ovarian surface epithelium versus 
ovarian cortex) and characteristics compared to the putative OSCs identified by Prof. Tilly and 
other groups (Clarkson et al., 2018; Silvestris et al., 2018; White et al., 2012). In order to be 
coherent with the previously reported studies on putative OSCs from adult human ovarian 
cortex, we followed the details regarding the centrifugation speed recommended in the original 
protocol (Woods et al., 2013).  
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5. CONCLUSIONS 
In this thesis, we studied the impact of chemotherapy on pediatric and young adult human 
ovaries of cancer patients. Quality and quantity of ovarian follicles and quality of ovarian 
stroma were analyzed with regards to chemotherapy treatment prior to ovarian 
cryopreservation and compared to untreated cancer patients’ ovarian tissue. Furthermore, we 
assessed the cell type composition of the adult human ovarian cortex with a particular focus on 
previously reported OSCs, isolated using FACS targeting DDX4. We characterized these 
DDX4 Ab-positive cells and investigated a possible existence of germline-like cells in the adult 
human ovary.  
 
The main findings of these studies are listed below. 
• Chemotherapy exposure alters quantity and quality of follicles in the ovarian tissue of 
pediatric and young adult ovaries: exposure to chemotherapy prior to tissue 
cryopreservation increases the density of atretic primordial and intermediary follicles 
and decreases the size of intact primordial and intermediary follicles and their oocyte 
nuclei. It also decreases the density of intact primary follicles. 
 
• Neither follicle activation nor DNA damage in follicles could be determined with 
certainty as the main underlying mechanism of observed ovarian follicle alterations 
following chemotherapy treatment. 
 
• Chemotherapy exposure alters the ovarian stroma of pediatric and young adult ovaries. 
An increased DNA damage and large fibrotic areas were observed in patients exposed 
to chemotherapy prior to cryopreservation. 
 
• Six main cell types were found to constitute the cortex of adult human ovaries from 
GRPs and C-sec patients: oocytes, immune cells, granulosa cells, endothelial cells, 
perivascular cells and stroma. 
 
• All somatic cell types are present in both the cortex and the medullary region of the 
adult human ovary. However, a specific sub-population of granulosa cells was found 
in the cortex. In addition, oocytes were found in the cortex. 
 
• Putative OSCs isolated from the adult human ovarian cortex using DDX4-targeted 
FACS do not express germline markers but display a perivascular cell nature. 
 
• No cells resembling germline stem cells could be detected in the adult human ovarian 
cortex by single-cell transcriptome analysis. 
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Following our findings in study I, ovarian tissue cryopreservation should be performed prior to 
exposure of chemotherapy if the patient’s condition allows to avoid the negative impact on 
ovarian follicle and stroma health. 
Following our findings in study II, the current dogma of a limited female ovarian reserve still 
holds true and does not motivate the existence of germline-like stem cells in the adult human 
ovary in vivo. 
 
With these studies, we make small steps towards a better understanding of the human ovary. 
However, many more steps are to come to fully unravel the complexity of this organ and the 
great potential it holds as a paramount piece in the puzzle called female fertility.  
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6. FUTURE PERSPECTIVES 
Many see the ultimate solution to female fertility-related problems being the in vitro production 
of human oocytes. The development of a robust system to derive mature and functional oocytes 
(either from pluripotent stem cells or immature primordial follicles) would pave the way to 
novel fertility treatment options. Not only would it eliminate the potential risk of re-introducing 
malignant cells in OTT in cancer survivors but could also serve as a much-needed test system 
for molecular signaling pathways involved in folliculogenesis, and compounds suspected to be 
toxic to female germ cells, such as chemotherapy agents and endocrine disruptive chemicals.  
 
In mouse, the possibility to generate offspring from in vitro derived (from PGCs, iPSCs and 
ESCs to primordial follicles) (Hikabe et al., 2016; Morohaku et al., 2016) and in vitro grown 
oocytes (from primordial to fertilizable oocytes) (Eppig et al., 1996) was successfully proven. 
In human, first reports of in vitro derived oocytes (from iPSCs to oogonia) (Yamashiro et al., 
2018) and in vitro matured oocytes (from cortical follicles to Metaphase II oocytes) 
(McLaughlin et al., 2018) hold tremendous promise. Several research groups are actively 
working on the development of systems to mature follicles in the laboratory.  
 
One strategy lies in the construction of artificial ovaries (Chiti et al., 2018; Laronda et al., 2017; 
Pors et al., 2019). Artificial ovarian constructs have been proposed as a scaffold providing an 
appropriate environment (matrix and somatic/stromal cells) for ovarian follicle survival and 
growth in vitro. It is known that for primordial follicles to mature, a migration from the stiff 
cortical area towards the looser medullary region is necessary (Nagamatsu et al., 2019). For 
sure, this architecture of varying rigidity will be crucial for successful folliculogenesis in vitro. 
The Woodruff lab has demonstrated first successful reimplantation of such constructs in mice 
resulting in ovulated and fertilizable oocytes with healthy offspring (Laronda et al., 2017). The 
ultimate proof of a fully matured, in vitro derived human oocyte will be to fertilize it and 
investigate embryo morphology and blastocyst development in vitro based on criteria used in 
Reproductive Medicine centers. 
 
Despite the field moving forward, we still encounter big knowledge gaps in fundamental 
questions regarding ovary biology, such as:  
• Why are humans born with an ovarian reserve comprised of millions of primordial 
follicles that starts to decline already before birth? Do atretic follicles provide any 
function prior to their death? 
 
• Is there an inherent difference between follicles destined to undergo atresia and follicles 
that achieve maturity? Is there a difference between follicles in the pre-pubertal and the 
adult ovary or is the developmental potential of all follicles the same? If there is a 
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difference between pre-pubertal and adult ovarian follicles, is it inherent or determined 
by their surrounding niche that is changing with age? 
 
• Are there OSCs in the adult ovary and if so, what is their physiological role? Why do 
women undergo menopause if there was a constant supply of new follicles from OSCs? 
I believe that understanding the differences between pre-pubertal and adult ovaries is of utmost 
importance and will provide more insight into some basic questions raised above. For example, 
single-follicle RNA-sequencing of different stages (primordial, primary and secondary) 
isolated from pre-pubertal and adult ovaries could give us first hints regarding inherent 
properties and developmental potential that might change during reproductive aging. In a recent 
study, ovaries of non-human primates were investigated with regards to aging and discovered 
the role of antioxidant pathways in age-related fertility decline (Wang et al., 2020). 
 
Additionally, comparing the diversity of ovarian cell types within the stromal compartment of 
pre-pubertal and adult ovaries might reveal some insights into underlying mechanisms 
involved in follicle atresia, follicle activation or menopause. Using our established single-cell 
map of adult ovarian cortex as well as the published single-cell map of adult ovarian medulla 
(Fan et al., 2019), scRNA-seq of pre-pubertal human ovary could be indicative of crucial 
differences in somatic cell type and ovary niche composition. We are currently observing how 
the stem cell niche is being discovered and its importance revealed in other human organs. The 
niche, or cellular environment, of tissue stem cells emits cues to either maintain their quiescent 
state or promote their differentiation. Similarly, in the ovary, it would be interesting to study 
the stromal cell type complexity. Do we see certain stromal cell types in proximity to primordial 
follicles maintaining their dormancy compared to those that have been activated and start 
growing?  
 
Once we better understand the ovarian follicles’ microenvironment in a healthy state at 
different ages, we might also be able to i) mimic those conditions in vitro and ii) protect the 
ovaries from damage e.g. induced by anti-cancer therapy, endocrine disruptors or aging. 
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